CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pentoside
Accession: CHEBI:35312
browse the term
Synonyms: related_synonym: pentosides
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
4-nitrophenyl beta-D-xyloside inhibits the reaction [FSHB protein results in increased activity of PDE4A protein]
CTD
PMID:17261351
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Pde4a
phosphodiesterase 4A
multiple interactions
EXP
4-nitrophenyl beta-D-xyloside inhibits the reaction [FSHB protein results in increased activity of PDE4A protein]
CTD
PMID:17261351
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Vidarabine results in increased activity of NR1I2 protein
CTD
PMID:25455453
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Abcb1a
ATP binding cassette subfamily B member 1A
affects response to substance increases expression
ISO
ABCB1 protein affects the susceptibility to Cytarabine Cytarabine results in increased expression of ABCB1
CTD
PMID:11573427 PMID:17852453
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
affects response to substance
ISO
ABCC1 protein affects the susceptibility to Cytarabine
CTD
PMID:17852453
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
increases expression
ISO
Cytarabine results in increased expression of ACAP1 mRNA
CTD
PMID:19194470
NCBI chr10:54,605,323...54,619,472
Ensembl chr10:54,605,323...54,619,472
G
Ache
acetylcholinesterase
multiple interactions increases activity
EXP
betanin inhibits the reaction [Cytarabine results in increased activity of ACHE protein]; thymoquinone inhibits the reaction [Cytarabine results in increased activity of ACHE protein]; Vitamin D inhibits the reaction [Cytarabine results in increased activity of ACHE protein]
CTD
PMID:36419121
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acta1
actin, alpha 1, skeletal muscle
increases expression
ISO
Cytarabine results in increased expression of ACTA1 mRNA
CTD
PMID:21198554
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Actc1
actin, alpha, cardiac muscle 1
decreases expression
ISO
Cytarabine results in decreased expression of ACTC1 mRNA
CTD
PMID:21198554
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
G
Adam19
ADAM metallopeptidase domain 19
decreases expression
ISO
Cytarabine results in decreased expression of ADAM19 mRNA
CTD
PMID:21198554
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
Cytarabine results in decreased expression of ADAMTS1 mRNA
CTD
PMID:21198554
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
decreases expression
ISO
Cytarabine results in decreased expression of ADAMTS9 mRNA
CTD
PMID:21198554
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
G
Adgrb3
adhesion G protein-coupled receptor B3
increases expression
ISO
Cytarabine results in increased expression of ADGRB3 mRNA
CTD
PMID:21198554
NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of ADIPOQ mRNA
CTD
PMID:23264188
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Afap1l2
actin filament associated protein 1-like 2
decreases expression
ISO
Cytarabine results in decreased expression of AFAP1L2 mRNA
CTD
PMID:21198554
NCBI chr 1:255,964,238...256,060,828
Ensembl chr 1:255,964,238...256,060,820
G
Ahi1
Abelson helper integration site 1
increases expression
ISO
Cytarabine results in increased expression of AHI1 protein alternative form
CTD
PMID:19379585
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
G
Ahnak
AHNAK nucleoprotein
decreases expression
ISO
Cytarabine results in decreased expression of AHNAK mRNA
CTD
PMID:21198554
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Aif1l
allograft inflammatory factor 1-like
increases expression
ISO
Cytarabine results in increased expression of AIF1L mRNA
CTD
PMID:21198554
NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023
G
Akr1b8
aldo-keto reductase family 1, member B8
decreases expression
ISO
Cytarabine results in decreased expression of AKR1B15 mRNA
CTD
PMID:21198554
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
G
Alpk2
alpha-kinase 2
decreases expression
ISO
Cytarabine results in decreased expression of ALPK2 mRNA
CTD
PMID:21198554
NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
G
Angptl2
angiopoietin-like 2
decreases expression
ISO
Cytarabine results in decreased expression of ANGPTL2 mRNA
CTD
PMID:21198554
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
Anks1a
ankyrin repeat and sterile alpha motif domain containing 1A
decreases expression
ISO
Cytarabine results in decreased expression of ANKS1A mRNA
CTD
PMID:21198554
NCBI chr20:5,963,658...6,117,139
Ensembl chr20:5,963,678...6,117,148
G
Ano8
anoctamin 8
increases expression
ISO
Cytarabine results in increased expression of ANO8 mRNA
CTD
PMID:21198554
NCBI chr16:18,163,853...18,173,248
Ensembl chr16:18,163,843...18,173,545
G
Anxa2
annexin A2
decreases expression increases expression
ISO
Cytarabine results in decreased expression of ANXA2 mRNA Cytarabine results in increased expression of ANXA2 mRNA
CTD
PMID:12165291 PMID:21198554
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa6
annexin A6
decreases expression
ISO
Cytarabine results in decreased expression of ANXA6 mRNA
CTD
PMID:21198554
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
G
Anxa8
annexin A8
decreases expression
ISO
Cytarabine results in decreased expression of ANXA8 mRNA
CTD
PMID:21198554
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Aplnr
apelin receptor
decreases expression
ISO
Cytarabine results in decreased expression of APLNR mRNA
CTD
PMID:21198554
NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050
G
Aqp1
aquaporin 1
decreases expression
ISO
Cytarabine results in decreased expression of AQP1 mRNA
CTD
PMID:21198554
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Arg2
arginase 2
decreases expression
ISO
Cytarabine results in decreased expression of ARG2 mRNA
CTD
PMID:21198554
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgap44
Rho GTPase activating protein 44
decreases expression
ISO
Cytarabine results in decreased expression of ARHGAP44 mRNA
CTD
PMID:21198554
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
G
Arhgdib
Rho GDP dissociation inhibitor beta
decreases expression
ISO
Cytarabine results in decreased expression of ARHGDIB mRNA
CTD
PMID:21198554
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
G
Arhgef3
Rho guanine nucleotide exchange factor 3
decreases expression
ISO
Cytarabine results in decreased expression of ARHGEF3 mRNA
CTD
PMID:21198554
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
increases expression
ISO
Cytarabine results in increased expression of ARL6IP5 protein
CTD
PMID:16430862
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Art4
ADP-ribosyltransferase 4
decreases expression
ISO
Cytarabine results in decreased expression of ART4 mRNA
CTD
PMID:21198554
NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665
G
Art5
ADP-ribosyltransferase 5
decreases expression
ISO
Cytarabine results in decreased expression of ART5 mRNA
CTD
PMID:21198554
NCBI chr 1:156,473,362...156,483,324
Ensembl chr 1:156,473,362...156,483,324
G
Atf3
activating transcription factor 3
decreases expression increases expression
ISO
Cytarabine results in decreased expression of ATF3 mRNA Cytarabine results in increased expression of ATF3 mRNA
CTD
PMID:21198554 PMID:33770205
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atl1
atlastin GTPase 1
increases expression
ISO
Cytarabine results in increased expression of ATL1 mRNA
CTD
PMID:21198554
NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204
G
Atn1
atrophin 1
increases expression
ISO
Cytarabine results in increased expression of ATN1 mRNA
CTD
PMID:21198554
NCBI chr 4:157,554,287...157,568,092
Ensembl chr 4:157,551,276...157,568,132
G
Atp10d
ATPase phospholipid transporting 10D (putative)
increases expression
ISO
Cytarabine results in increased expression of ATP10D mRNA
CTD
PMID:19194470
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
decreases expression
ISO
Cytarabine results in decreased expression of ATP1B1 mRNA
CTD
PMID:21198554
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Atp7b
ATPase copper transporting beta
decreases expression
ISO
Cytarabine results in decreased expression of ATP7B mRNA
CTD
PMID:21198554
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Atp8b4
ATPase phospholipid transporting 8B4 (putative)
decreases expression
ISO
Cytarabine results in decreased expression of ATP8B4 mRNA
CTD
PMID:21198554
NCBI chr 3:113,554,979...113,757,635
Ensembl chr 3:113,556,192...113,757,225
G
Axl
Axl receptor tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of AXL mRNA
CTD
PMID:21198554
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
B2m
beta-2 microglobulin
increases expression
ISO
Cytarabine results in increased expression of B2M protein
CTD
PMID:11096300
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B4galt7
beta-1,4-galactosyltransferase 7
decreases expression
ISO
Cytarabine results in decreased expression of B4GALT7 mRNA
CTD
PMID:21198554
NCBI chr17:9,018,514...9,027,591
Ensembl chr17:9,018,935...9,027,573
G
Bag3
BAG cochaperone 3
decreases expression
ISO
Cytarabine results in decreased expression of BAG3 mRNA
CTD
PMID:21198554
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
decreases expression
ISO
Cytarabine results in decreased expression of BAIAP2L1 mRNA
CTD
PMID:21198554
NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP ISO
Cytarabine results in increased expression of BAX mRNA [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein; Cytarabine results in increased expression of BAX protein
CTD
PMID:10200513 PMID:15203180 PMID:16129037 PMID:17490525
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
affects response to substance
ISO
BBC3 protein affects the susceptibility to Cytarabine
CTD
PMID:20477944
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcar3
BCAR3 adaptor protein, NSP family member
decreases expression
ISO
Cytarabine results in decreased expression of BCAR3 mRNA
CTD
PMID:21198554
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bche
butyrylcholinesterase
increases activity multiple interactions
EXP
Cytarabine results in increased activity of BCHE protein betanin inhibits the reaction [Cytarabine results in increased activity of BCHE protein]
CTD
PMID:36419121
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases degradation decreases expression
ISO
[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]; edelfosine promotes the reaction [Cytarabine results in decreased expression of BCL2 protein] Cytarabine results in increased degradation of BCL2 protein Cytarabine results in decreased expression of BCL2 mRNA; Cytarabine results in decreased expression of BCL2 protein
CTD
PMID:1450413 PMID:8840993 PMID:9295281 PMID:12853972 PMID:16129037 PMID:17490525 PMID:21182165 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]
CTD
PMID:8840993
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bhlhe22
basic helix-loop-helix family, member e22
increases expression
ISO
Cytarabine results in increased expression of BHLHE22 mRNA
CTD
PMID:21198554
NCBI chr 2:100,486,400...100,489,510
Ensembl chr 2:100,486,400...100,489,510
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased expression of BID protein
CTD
PMID:12780785
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Bin2
bridging integrator 2
increases expression
ISO
Cytarabine results in increased expression of BIN2 mRNA
CTD
PMID:19194470
NCBI chr 7:131,742,001...131,768,208
Ensembl chr 7:131,742,002...131,786,285
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
Cytarabine results in decreased expression of BMP4 mRNA
CTD
PMID:21198554
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bmp5
bone morphogenetic protein 5
decreases expression
ISO
Cytarabine results in decreased expression of BMP5 mRNA
CTD
PMID:21198554
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
G
Bnc1
basonuclin zinc finger protein 1
decreases expression
ISO
Cytarabine results in decreased expression of BNC1 mRNA
CTD
PMID:21198554
NCBI chr 1:135,917,676...135,943,333
Ensembl chr 1:135,917,687...135,943,333
G
Bnc2
basonuclin zinc finger protein 2
decreases expression
ISO
Cytarabine results in decreased expression of BNC2 mRNA
CTD
PMID:21198554
NCBI chr 5:98,679,071...99,016,044
Ensembl chr 5:98,687,410...99,079,426
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
Cytarabine results in decreased expression of BORA mRNA
CTD
PMID:17374387
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
decreases expression
ISO
Cytarabine results in decreased expression of BPNT2 mRNA
CTD
PMID:21198554
NCBI chr 5:17,775,684...17,802,570
Ensembl chr 5:17,772,608...17,802,570
G
Brca2
BRCA2, DNA repair associated
increases expression
ISO
Cytarabine results in increased expression of BRCA2 mRNA
CTD
PMID:19194470
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
Cytarabine results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
Cytarabine results in decreased expression of BST2 mRNA
CTD
PMID:21198554
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Cytarabine results in increased expression of BTG2 mRNA
CTD
PMID:21382384
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
Cytarabine results in decreased expression of C2CD2 mRNA
CTD
PMID:21198554
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C3ar1
complement C3a receptor 1
increases expression
ISO
Cytarabine results in increased expression of C3AR1 mRNA
CTD
PMID:19194470
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
G
Cab39l
calcium binding protein 39-like
decreases expression
ISO
Cytarabine results in decreased expression of CAB39L mRNA
CTD
PMID:21198554
NCBI chr15:33,606,588...33,710,518
Ensembl chr15:33,606,694...33,743,545
G
Calb1
calbindin 1
decreases expression
EXP
Cytarabine results in decreased expression of CALB1 protein
CTD
PMID:22212197
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Calb2
calbindin 2
decreases expression
ISO
Cytarabine results in decreased expression of CALB2 mRNA
CTD
PMID:21198554
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Calcr
calcitonin receptor
increases response to substance
ISO
CALCR results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
Cytarabine results in increased expression of CAMK2N1 mRNA
CTD
PMID:21198554
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Capn1
calpain 1
decreases expression
ISO
Cytarabine results in decreased expression of CAPN1 mRNA
CTD
PMID:21198554
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Car12
carbonic anhydrase 12
decreases expression
ISO
Cytarabine results in decreased expression of CA12 mRNA
CTD
PMID:21198554
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
Cytarabine results in decreased expression of CARMIL1 mRNA
CTD
PMID:21198554
NCBI chr17:40,807,921...41,088,326
Ensembl chr17:40,808,389...41,088,326
G
Casp3
caspase 3
multiple interactions increases activity increases expression
ISO EXP
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein Cytarabine results in increased activity of CASP3 protein Cytarabine results in increased expression of CASP3 protein
CTD
PMID:8840993 PMID:12780785 PMID:12781215 PMID:14766721 PMID:22212197 PMID:25003661 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Cytarabine results in increased expression of and results in increased cleavage of CASP8 protein
CTD
PMID:12780785 PMID:18549619 PMID:22010212
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cat
catalase
multiple interactions decreases expression
EXP
Thioctic Acid inhibits the reaction [Cytarabine results in decreased expression of CAT protein]
CTD
PMID:33225757
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cavin1
caveolae associated protein 1
decreases expression
ISO
Cytarabine results in decreased expression of CAVIN1 mRNA
CTD
PMID:21198554
NCBI chr10:85,884,100...85,896,136
Ensembl chr10:85,889,036...85,896,120
G
Cavin3
caveolae associated protein 3
decreases expression
ISO
Cytarabine results in decreased expression of CAVIN3 mRNA
CTD
PMID:21198554
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
G
Ccdc102a
coiled-coil domain containing 102A
decreases expression
ISO
Cytarabine results in decreased expression of CCDC102A mRNA
CTD
PMID:21198554
NCBI chr19:10,102,543...10,118,657
Ensembl chr19:10,103,361...10,118,657
G
Ccdc112
coiled-coil domain containing 112
increases expression
ISO
Cytarabine results in increased expression of CCDC112 mRNA
CTD
PMID:21198554
NCBI chr18:38,998,139...39,032,329
Ensembl chr18:38,998,139...39,032,329
G
Ccdc15
coiled-coil domain containing 15
increases expression
ISO
Cytarabine results in increased expression of CCDC15 mRNA
CTD
PMID:21198554
NCBI chr 8:36,991,147...37,068,849
Ensembl chr 8:36,998,867...37,068,919
G
Cckbr
cholecystokinin B receptor
decreases expression
ISO
Cytarabine results in decreased expression of CCKBR mRNA
CTD
PMID:21198554
NCBI chr 1:159,771,733...159,781,738
Ensembl chr 1:159,771,733...159,814,881
G
Ccnd3
cyclin D3
decreases expression
ISO
Cytarabine results in decreased expression of CCND3 mRNA
CTD
PMID:21198554
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccne2
cyclin E2
increases expression
ISO
Cytarabine results in increased expression of CCNE2 mRNA
CTD
PMID:21198554
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccng1
cyclin G1
increases expression
EXP
Cytarabine results in increased expression of CCNG1 mRNA
CTD
PMID:14766721 PMID:15203180
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Cd44
CD44 molecule
decreases expression
ISO
Cytarabine results in decreased expression of CD44 mRNA
CTD
PMID:21198554
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd8a
CD8 subunit alpha
increases expression
ISO
Cytarabine results in increased expression of CD8A mRNA
CTD
PMID:19194470
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
G
Cdc42ep5
CDC42 effector protein 5
decreases expression
ISO
Cytarabine results in decreased expression of CDC42EP5 mRNA
CTD
PMID:21198554
NCBI chr 1:70,035,921...70,038,990
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
Cytarabine results in decreased expression of CDCA8 mRNA
CTD
PMID:17374387
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
G
Cdh11
cadherin 11
decreases expression
ISO
Cytarabine results in decreased expression of CDH11 mRNA
CTD
PMID:21198554
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdh3
cadherin 3
decreases expression
ISO
Cytarabine results in decreased expression of CDH3 mRNA
CTD
PMID:21198554
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Cytarabine results in increased expression of CDK5R1 mRNA
CTD
PMID:33770205
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO EXP
[fludarabine co-treated with Cytarabine co-treated with Docetaxel] results in increased expression of CDKN1A protein; Caffeine inhibits the reaction [Cytarabine results in increased expression of CDKN1A protein] Cytarabine results in increased expression of CDKN1A mRNA; Cytarabine results in increased expression of CDKN1A protein
CTD
PMID:9703875 PMID:14766721 PMID:15203180 PMID:17977830 PMID:33770205
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
Cytarabine results in decreased expression of CDKN1C mRNA
CTD
PMID:21198554
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cebpd
CCAAT/enhancer binding protein delta
decreases expression
ISO
Cytarabine results in decreased expression of CEBPD mRNA
CTD
PMID:21198554
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
G
Celf3
CUGBP, Elav-like family member 3
increases expression
ISO
Cytarabine results in increased expression of CELF3 mRNA
CTD
PMID:21198554
NCBI chr 2:182,116,034...182,130,163
Ensembl chr 2:182,116,073...182,130,163
G
Cemip
cell migration inducing hyaluronidase 1
decreases expression
ISO
Cytarabine results in decreased expression of CEMIP mRNA
CTD
PMID:21198554
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
G
Chat
choline O-acetyltransferase
increases activity
EXP
Cytarabine results in increased activity of CHAT protein
CTD
PMID:2900045
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
G
Chn1
chimerin 1
decreases expression
ISO
Cytarabine results in decreased expression of CHN1 mRNA
CTD
PMID:21198554
NCBI chr 3:58,509,822...58,676,462
Ensembl chr 3:58,510,536...58,676,490
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
ISO
Cytarabine results in decreased expression of CITED2 mRNA
CTD
PMID:21198554
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Ckb
creatine kinase B
increases expression
ISO
Cytarabine results in increased expression of CKB mRNA
CTD
PMID:21198554
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
ISO
Cytarabine results in decreased expression of CKS2 mRNA
CTD
PMID:17374387
NCBI chr17:13,570,611...13,575,770
G
Cldn15
claudin 15
decreases expression
ISO
Cytarabine results in decreased expression of CLDN15 mRNA
CTD
PMID:21198554
NCBI chr12:19,698,167...19,708,419
Ensembl chr12:19,698,337...19,706,819
G
Clec1b
C-type lectin domain family 1, member B
decreases expression
ISO
Cytarabine results in decreased expression of CLEC1B mRNA
CTD
PMID:21198554
NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291
G
Cnih2
cornichon family AMPA receptor auxiliary protein 2
increases expression
ISO
Cytarabine results in increased expression of CNIH2 mRNA
CTD
PMID:21198554
NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089
G
Cnr1
cannabinoid receptor 1
increases expression
ISO
Cytarabine results in increased expression of CNR1 mRNA
CTD
PMID:21198554
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Cntfr
ciliary neurotrophic factor receptor
increases expression
ISO
Cytarabine results in increased expression of CNTFR mRNA
CTD
PMID:21198554
NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392
G
Cntrl
centriolin
increases expression
ISO
Cytarabine results in increased expression of CNTRL mRNA
CTD
PMID:21198554
NCBI chr 3:18,428,147...18,500,362
Ensembl chr 3:18,428,103...18,500,380
G
Cobll1
cordon-bleu WH2 repeat protein-like 1
decreases expression
ISO
Cytarabine results in decreased expression of COBLL1 mRNA
CTD
PMID:21198554
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
G
Col13a1
collagen type XIII alpha 1 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL13A1 mRNA
CTD
PMID:21198554
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL18A1 mRNA
CTD
PMID:21198554
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL1A1 mRNA
CTD
PMID:21198554
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL1A2 mRNA
CTD
PMID:21198554
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL3A1 mRNA
CTD
PMID:21198554
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col5a1
collagen type V alpha 1 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL5A1 mRNA
CTD
PMID:21198554
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL5A2 mRNA
CTD
PMID:21198554
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a2
collagen type VI alpha 2 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL6A2 mRNA
CTD
PMID:21198554
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col6a3
collagen type VI alpha 3 chain
decreases expression
ISO
Cytarabine results in decreased expression of COL6A3 mRNA
CTD
PMID:21198554
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Col9a1
collagen type IX alpha 1 chain
increases expression
ISO
Cytarabine results in increased expression of COL9A1 mRNA
CTD
PMID:21198554
NCBI chr 9:26,585,034...26,668,222
Ensembl chr 9:26,585,034...26,668,213
G
Colec12
collectin sub-family member 12
decreases expression
ISO
Cytarabine results in decreased expression of COLEC12 mRNA
CTD
PMID:21198554
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
G
Cpz
carboxypeptidase Z
decreases expression
ISO
Cytarabine results in decreased expression of CPZ mRNA
CTD
PMID:21198554
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
G
Crabp1
cellular retinoic acid binding protein 1
increases expression
ISO
Cytarabine results in increased expression of CRABP1 mRNA
CTD
PMID:21198554
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
decreases expression
ISO
Cytarabine results in decreased expression of CRISPLD2 mRNA
CTD
PMID:21198554
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
G
Crtap
cartilage associated protein
decreases expression
ISO
Cytarabine results in decreased expression of CRTAP mRNA
CTD
PMID:21198554
NCBI chr 8:114,047,929...114,067,636
Ensembl chr 8:114,047,933...114,067,631
G
Cryab
crystallin, alpha B
decreases expression
ISO
Cytarabine results in decreased expression of CRYAB mRNA
CTD
PMID:21198554
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
Cytarabine results in decreased expression of CSNK1D mRNA
CTD
PMID:21198554
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Csrnp1
cysteine and serine rich nuclear protein 1
decreases expression
ISO
Cytarabine results in decreased expression of AXUD1 mRNA
CTD
PMID:21198554
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Ctsh
cathepsin H
decreases expression
ISO
Cytarabine results in decreased expression of CTSH mRNA
CTD
PMID:21198554
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
Ctsl
cathepsin L
decreases expression
ISO
Cytarabine results in decreased expression of CTSL mRNA
CTD
PMID:21198554
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Cytarabine results in increased expression of CXCR4 mRNA
CTD
PMID:19194470 PMID:21198554
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyb5a
cytochrome b5 type A
decreases expression
ISO
Cytarabine results in decreased expression of CYB5A mRNA
CTD
PMID:21198554
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
G
Cyb5d1
cytochrome b5 domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of CYB5D1 mRNA
CTD
PMID:21198554
NCBI chr10:54,113,428...54,117,744
Ensembl chr10:54,113,438...54,117,911
G
Cyb5r2
cytochrome b5 reductase 2
decreases expression
ISO
Cytarabine results in decreased expression of CYB5R2 mRNA
CTD
PMID:21198554
NCBI chr 1:161,655,862...161,664,359
Ensembl chr 1:161,655,864...161,664,097
G
Cyba
cytochrome b-245 alpha chain
decreases expression
ISO
Cytarabine results in decreased expression of CYBA mRNA
CTD
PMID:21198554
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Cytarabine results in decreased expression of CYP27A1 mRNA
CTD
PMID:21198554
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp4x1
cytochrome P450, family 4, subfamily x, polypeptide 1
decreases expression
ISO
Cytarabine results in decreased expression of CYP4X1 mRNA
CTD
PMID:21198554
NCBI chr 5:128,651,681...128,683,338
Ensembl chr 5:128,651,776...128,682,779
G
Cyth1
cytohesin 1
increases expression
ISO
Cytarabine results in increased expression of CYTH1 mRNA
CTD
PMID:19194470
NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760
G
Dab2
DAB adaptor protein 2
decreases expression
ISO
Cytarabine results in decreased expression of DAB2 mRNA
CTD
PMID:21198554
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
G
Dalrd3
DALR anticodon binding domain containing 3
decreases expression
ISO
Cytarabine results in decreased expression of DALRD3 mRNA
CTD
PMID:19194470
NCBI chr 8:109,264,100...109,268,560
Ensembl chr 8:109,265,676...109,268,568
G
Dbn1
drebrin 1
decreases expression
ISO
Cytarabine results in decreased expression of DBN1 mRNA
CTD
PMID:19194470
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Dck
deoxycytidine kinase
affects binding decreases response to substance
ISO EXP
Cytarabine binds to DCK protein Cytarabine binds to Dck protein DCK gene polymorphism results in decreased susceptibility to Cytarabine
CTD RGD
PMID:1318170 PMID:18381442 PMID:7532033
RGD:2300399
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
G
Dcn
decorin
decreases expression
ISO
Cytarabine results in decreased expression of DCN mRNA
CTD
PMID:21198554
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
ISO
Cytarabine results in decreased expression of DDR2 mRNA
CTD
PMID:21198554
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Dennd1a
DENN domain containing 1A
increases expression
ISO
Cytarabine results in increased expression of DENND1A mRNA
CTD
PMID:19194470
NCBI chr 3:21,564,749...22,052,057
Ensembl chr 3:21,564,749...22,052,062
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
Cytarabine results in decreased expression of DEPTOR mRNA
CTD
PMID:21198554
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Cytarabine results in decreased expression of DHCR24 mRNA
CTD
PMID:21198554
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dhfr
dihydrofolate reductase
increases expression
ISO
Cytarabine results in increased expression of DHFR mRNA
CTD
PMID:19194470
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Disp3
dispatched RND transporter family member 3
increases expression
ISO
Cytarabine results in increased expression of DISP3 mRNA
CTD
PMID:21198554
NCBI chr 5:158,672,015...158,720,806
Ensembl chr 5:158,672,015...158,720,806
G
Dnah2
dynein, axonemal, heavy chain 2
decreases expression
ISO
Cytarabine results in decreased expression of DNAH2 mRNA
CTD
PMID:21198554
NCBI chr10:54,142,648...54,268,901
Ensembl chr10:54,142,737...54,267,298
G
Dok4
docking protein 4
decreases expression
ISO
Cytarabine results in decreased expression of DOK4 mRNA
CTD
PMID:21198554
NCBI chr19:10,146,520...10,157,187
Ensembl chr19:10,146,474...10,158,203
G
Dsc2
desmocollin 2
decreases expression
ISO
Cytarabine results in decreased expression of DSC2 mRNA
CTD
PMID:21198554
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
G
Dsc3
desmocollin 3
decreases expression
ISO
Cytarabine results in decreased expression of DSC3 mRNA
CTD
PMID:21198554
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dusp4
dual specificity phosphatase 4
decreases expression
ISO
Cytarabine results in decreased expression of DUSP4 mRNA
CTD
PMID:19194470
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
E2f8
E2F transcription factor 8
increases expression
ISO
Cytarabine results in increased expression of E2F8 mRNA
CTD
PMID:33770205
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Edn1
endothelin 1
multiple interactions
ISO
EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] EDN1 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
ISO
Cytarabine results in decreased expression of EEF2 mRNA
CTD
PMID:21198554
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
decreases expression
ISO
Cytarabine results in decreased expression of EFEMP2 mRNA
CTD
PMID:21198554
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
G
Efhd1
EF-hand domain family, member D1
decreases expression
ISO
Cytarabine results in decreased expression of EFHD1 mRNA
CTD
PMID:21198554
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
G
Efna1
ephrin A1
decreases expression
ISO
Cytarabine results in decreased expression of EFNA1 mRNA
CTD
PMID:21198554
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
G
Egfl6
EGF-like-domain, multiple 6
decreases expression
ISO
Cytarabine results in decreased expression of EGFL6 mRNA
CTD
PMID:21198554
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
G
Egflam
EGF-like, fibronectin type III and laminin G domains
decreases expression
ISO
Cytarabine results in decreased expression of EGFLAM mRNA
CTD
PMID:21198554
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
G
Eif4h
eukaryotic translation initiation factor 4H
decreases expression
ISO
Cytarabine results in decreased expression of EIF4H mRNA
CTD
PMID:21198554
NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876
G
Eno3
enolase 3
decreases expression
ISO
Cytarabine results in decreased expression of ENO3 mRNA
CTD
PMID:21198554
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
increases expression
ISO
Cytarabine results in increased expression of ENTPD1 mRNA
CTD
PMID:19194470
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
G
Exog
exo/endonuclease G
decreases expression
ISO
Cytarabine results in decreased expression of EXOG mRNA
CTD
PMID:21198554
NCBI chr 8:119,184,974...119,204,819
Ensembl chr 8:119,185,136...119,204,672
G
Ext2
exostosin glycosyltransferase 2
decreases expression
ISO
Cytarabine results in decreased expression of EXT2 mRNA
CTD
PMID:21198554
NCBI chr 3:79,665,414...79,798,077
Ensembl chr 3:79,665,415...79,798,059
G
Ezr
ezrin
decreases expression
ISO
Cytarabine results in decreased expression of EZR mRNA
CTD
PMID:21198554
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F2
coagulation factor II, thrombin
affects expression
ISO
Cytarabine affects the expression of F2 protein
CTD
PMID:12542493
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fabp7
fatty acid binding protein 7
increases expression
ISO
Cytarabine results in increased expression of FABP7 mRNA
CTD
PMID:21198554
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fam111a
FAM111 trypsin like peptidase A
increases expression
ISO
Cytarabine results in increased expression of FAM111A mRNA
CTD
PMID:19194470
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fas
Fas cell surface death receptor
increases expression
EXP ISO
Cytarabine results in increased expression of FAS mRNA
CTD
PMID:14766721 PMID:15203180 PMID:33770205
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbln1
fibulin 1
decreases expression
ISO
Cytarabine results in decreased expression of FBLN1 mRNA
CTD
PMID:21198554
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo2
F-box protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FBXO2 mRNA
CTD
PMID:21198554
NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355
G
Fcgr2a
Fc gamma receptor 2A
increases expression
ISO
Cytarabine results in increased expression of FCGR2A mRNA
CTD
PMID:19194470
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Flnc
filamin C
decreases expression
ISO
Cytarabine results in decreased expression of FLNC mRNA
CTD
PMID:21198554
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
G
Flrt2
fibronectin leucine rich transmembrane protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FLRT2 mRNA
CTD
PMID:21198554
NCBI chr 6:114,777,547...114,872,688
Ensembl chr 6:114,777,599...114,872,785
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
Cytarabine results in decreased expression of FMO1 mRNA
CTD
PMID:21198554
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fmo4
flavin containing dimethylaniline monoxygenase 4
decreases expression
ISO
Cytarabine results in decreased expression of FMO4 mRNA
CTD
PMID:21198554
NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874
G
Frzb
frizzled-related protein
decreases expression
ISO
Cytarabine results in decreased expression of FRZB mRNA
CTD
PMID:21198554
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Fsip1
fibrous sheath interacting protein 1
increases expression
ISO
Cytarabine results in increased expression of FSIP1 mRNA
CTD
PMID:21198554
NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167
G
Fyb2
FYN binding protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FYB2 mRNA
CTD
PMID:21198554
NCBI chr 5:119,677,116...119,800,911
Ensembl chr 5:119,677,204...119,800,910
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
increases expression
ISO
Cytarabine results in increased expression of FYN mRNA
CTD
PMID:21198554
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
ISO
Cytarabine results in decreased expression of GABARAPL1 mRNA
CTD
PMID:21198554
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gabrp
gamma-aminobutyric acid type A receptor subunit pi
increases expression
ISO
Cytarabine results in increased expression of GABRP mRNA
CTD
PMID:21198554
NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Cytarabine results in increased expression of GADD45A mRNA
CTD
PMID:33770205
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
Cytarabine results in decreased expression of GALNT10 mRNA
CTD
PMID:21198554
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
G
Gap43
growth associated protein 43
increases expression
ISO
Cytarabine results in increased expression of GAP43 mRNA
CTD
PMID:21198554
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases activity affects localization increases response to substance
ISO
Cytarabine results in decreased activity of GAPDH protein Cytarabine affects the localization of GAPDH protein GAPDH protein results in increased susceptibility to Cytarabine
CTD
PMID:19628630
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gata5
GATA binding protein 5
decreases expression
ISO
Cytarabine results in decreased expression of GATA5 mRNA
CTD
PMID:21198554
NCBI chr 3:167,418,563...167,426,751
Ensembl chr 3:167,418,565...167,426,751
G
Gbp4
guanylate binding protein 4
decreases expression
ISO
Cytarabine results in decreased expression of GBP4 mRNA
CTD
PMID:21198554
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gca
grancalcin
decreases expression
ISO
Cytarabine results in decreased expression of GCA mRNA
CTD
PMID:21198554
NCBI chr 3:47,297,320...47,329,913
Ensembl chr 3:47,297,383...47,328,581
G
Gcnt2
glucosaminyl (N-acetyl) transferase 2
decreases expression
ISO
Cytarabine results in decreased expression of GCNT2 mRNA
CTD
PMID:21198554
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
G
Ghr
growth hormone receptor
decreases expression
ISO
Cytarabine results in decreased expression of GHR mRNA
CTD
PMID:21198554
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gls
glutaminase
decreases expression
ISO
Cytarabine results in decreased expression of GLS mRNA
CTD
PMID:21198554
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gnb3
G protein subunit beta 3
decreases expression
ISO
Cytarabine results in decreased expression of GNB3 mRNA
CTD
PMID:21198554
NCBI chr 4:157,639,468...157,645,171
Ensembl chr 4:157,639,469...157,645,173
G
Gper1
G protein-coupled estrogen receptor 1
decreases expression
ISO
Cytarabine results in decreased expression of GPER1 mRNA
CTD
PMID:21198554
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Gpm6a
glycoprotein m6a
increases expression
ISO
Cytarabine results in increased expression of GPM6A mRNA
CTD
PMID:21198554
NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
G
Gpr19
G protein-coupled receptor 19
increases expression
ISO
Cytarabine results in increased expression of GPR19 mRNA
CTD
PMID:21198554
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
G
Gpr83
G protein-coupled receptor 83
decreases expression
ISO
Cytarabine results in decreased expression of GPR83 mRNA
CTD
PMID:21198554
NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028
G
Gprc5c
G protein-coupled receptor, class C, group 5, member C
decreases expression
ISO
Cytarabine results in decreased expression of GPRC5C mRNA
CTD
PMID:21198554
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
increases expression
ISO
Cytarabine results in increased expression of GRIA2 mRNA
CTD
PMID:21198554
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
G
Grk5
G protein-coupled receptor kinase 5
increases expression
ISO
Cytarabine results in increased expression of GRK5 mRNA
CTD
PMID:19194470
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
G
Grpr
gastrin releasing peptide receptor
decreases expression
ISO
Cytarabine results in decreased expression of GRPR mRNA
CTD
PMID:21198554
NCBI chr X:30,998,425...31,038,442
Ensembl chr X:30,998,416...31,038,442
G
Gstcd
glutathione S-transferase, C-terminal domain containing
increases expression
ISO
Cytarabine results in increased expression of GSTCD mRNA
CTD
PMID:19194470
NCBI chr 2:221,499,732...221,591,888
Ensembl chr 2:221,499,083...221,591,857
G
Gstm1
glutathione S-transferase mu 1
affects response to substance
ISO
GSTM1 gene polymorphism affects the susceptibility to Cytarabine
CTD
PMID:15713801
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gtpbp1
GTP binding protein 1
increases expression
ISO
Cytarabine results in increased expression of GTPBP1 mRNA
CTD
PMID:19194470
NCBI chr 7:111,248,254...111,272,705
Ensembl chr 7:111,248,254...111,272,705
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of GUCY1A1 mRNA
CTD
PMID:21198554
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
G
H1f2
H1.2 linker histone, cluster member
decreases expression
ISO
Cytarabine results in decreased expression of H1-2 mRNA
CTD
PMID:21198554
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
H2aj
H2A.J histone
decreases expression
ISO
Cytarabine results in decreased expression of H2AJ mRNA
CTD
PMID:21198554
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
G
H2ax
H2A.X variant histone
increases phosphorylation
ISO
Cytarabine results in increased phosphorylation of H2AX protein
CTD
PMID:19628630 PMID:34510228
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hand1
heart and neural crest derivatives expressed 1
decreases expression
ISO
Cytarabine results in decreased expression of HAND1 mRNA
CTD
PMID:21198554
NCBI chr10:42,006,646...42,009,213
Ensembl chr10:42,006,651...42,009,213
G
Hand2
heart and neural crest derivatives expressed 2
decreases expression
ISO
Cytarabine results in decreased expression of HAND2 mRNA
CTD
PMID:21198554
NCBI chr16:32,917,448...32,920,791
Ensembl chr16:32,917,823...32,919,891
G
Hapln1
hyaluronan and proteoglycan link protein 1
decreases expression
ISO
Cytarabine results in decreased expression of HAPLN1 mRNA
CTD
PMID:21198554
NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
G
Has2
hyaluronan synthase 2
decreases expression
ISO
Cytarabine results in decreased expression of HAS2 mRNA
CTD
PMID:21198554
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Hcfc1r1
host cell factor C1 regulator 1
decreases expression
ISO
Cytarabine results in decreased expression of HCFC1R1 mRNA
CTD
PMID:21198554
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
G
Hes5
hes family bHLH transcription factor 5
increases expression
ISO
Cytarabine results in increased expression of HES5 mRNA
CTD
PMID:21198554
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
decreases expression
ISO
Cytarabine results in decreased expression of HEY1 mRNA
CTD
PMID:33770205
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Cytarabine results in increased expression of HIF1A mRNA
CTD
PMID:23264188
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
decreases response to substance increases secretion
ISO
HMGB1 protein results in decreased susceptibility to Cytarabine Cytarabine results in increased secretion of HMGB1 protein
CTD
PMID:27807322
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
Cytarabine results in decreased expression of HMGCS2 mRNA
CTD
PMID:21198554
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
Cytarabine results in decreased expression of HNRNPA3 mRNA
CTD
PMID:21198554
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Hoxa2
homeobox A2
increases expression
ISO
Cytarabine results in increased expression of HOXA2 mRNA
CTD
PMID:21198554
NCBI chr 4:81,262,668...81,266,970
Ensembl chr 4:81,262,768...81,265,044
G
Hoxa5
homeo box A5
increases expression
ISO
Cytarabine results in increased expression of HOXA5 mRNA
CTD
PMID:21198554
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
G
Hoxb4
homeo box B4
decreases expression
ISO
Cytarabine results in decreased expression of HOXB4 mRNA
CTD
PMID:21198554
NCBI chr10:81,284,552...81,287,134
Ensembl chr10:81,284,552...81,287,128
G
Hoxb6
homeo box B6
decreases expression
ISO
Cytarabine results in decreased expression of HOXB6 mRNA
CTD
PMID:21198554
NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449
G
Hoxb8
homeo box B8
decreases expression
ISO
Cytarabine results in decreased expression of HOXB8 mRNA
CTD
PMID:21198554
NCBI chr10:81,248,313...81,251,261
Ensembl chr10:81,248,887...81,250,638
G
Hoxc6
homeo box C6
decreases expression
ISO
Cytarabine results in decreased expression of HOXC6 mRNA
CTD
PMID:21198554
NCBI chr 7:134,138,017...134,148,899
Ensembl chr 7:134,135,502...134,148,392
G
Hoxc8
homeobox C8
decreases expression
ISO
Cytarabine results in decreased expression of HOXC8 mRNA
CTD
PMID:21198554
NCBI chr 7:134,127,937...134,130,503
Ensembl chr 7:134,127,913...134,130,503
G
Hs3st1
heparan sulfate-glucosamine 3-sulfotransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of HS3ST1 mRNA
CTD
PMID:21198554
NCBI chr14:71,185,826...71,223,263
Ensembl chr14:71,185,682...71,223,248
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Cytarabine results in increased expression of HSPA6 mRNA
CTD
PMID:19194470
NCBI chr13:83,273,176...83,274,317
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
Cytarabine results in decreased expression of HTRA1 mRNA
CTD
PMID:21198554
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
ISO
Cytarabine results in decreased expression of IGFBP3 mRNA
CTD
PMID:21198554
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
Cytarabine results in decreased expression of IGFBP5 mRNA
CTD
PMID:21198554
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il6
interleukin 6
increases expression
ISO
Cytarabine results in increased expression of IL6 protein
CTD
PMID:11745875
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
Cytarabine results in increased expression of INA mRNA
CTD
PMID:21198554
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Irx5
iroquois homeobox 5
increases expression
ISO
Cytarabine results in increased expression of IRX5 mRNA
CTD
PMID:21198554
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
Cytarabine results in decreased expression of ITGB5 mRNA
CTD
PMID:21198554
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Itm2c
integral membrane protein 2C
decreases expression
ISO
Cytarabine results in decreased expression of ITM2C mRNA
CTD
PMID:21198554
NCBI chr 9:86,545,927...86,559,745
Ensembl chr 9:86,545,921...86,559,742
G
Jam2
junctional adhesion molecule 2
increases expression
ISO
Cytarabine results in increased expression of JAM2 mRNA
CTD
PMID:21198554
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Cytarabine results in increased expression of JUN; Cytarabine results in increased expression of JUN mRNA
CTD
PMID:1450413 PMID:7949469
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kank4
KN motif and ankyrin repeat domains 4
decreases expression
ISO
Cytarabine results in decreased expression of KANK4 mRNA
CTD
PMID:21198554
NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
decreases expression
ISO
Cytarabine results in decreased expression of KCNN2 mRNA
CTD
PMID:21198554
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
G
Kctd12
potassium channel tetramerization domain containing 12
decreases expression
ISO
Cytarabine results in decreased expression of KCTD12 mRNA
CTD
PMID:21198554
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
decreases expression
ISO
Cytarabine results in decreased expression of KDELR3 mRNA
CTD
PMID:21198554
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kiaa1671
KIAA1671 homolog
decreases expression
ISO
Cytarabine results in decreased expression of KIAA1671 mRNA
CTD
PMID:21198554
NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157
G
Kif15
kinesin family member 15
increases expression
ISO
Cytarabine results in increased expression of KIF15 mRNA
CTD
PMID:21198554
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Klhl41
kelch-like family member 41
decreases expression
ISO
Cytarabine results in decreased expression of KLHL41 mRNA
CTD
PMID:21198554
NCBI chr 3:54,434,291...54,447,415
Ensembl chr 3:54,434,234...54,449,222
G
Klk6
kallikrein related-peptidase 6
decreases expression
ISO
Cytarabine results in decreased expression of KLK6 mRNA
CTD
PMID:21198554
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
G
Kmo
kynurenine 3-monooxygenase
increases response to substance
ISO
KMO results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kmt2a
lysine methyltransferase 2A
increases response to substance
ISO
KMT2A gene mutant form results in increased susceptibility to Cytarabine
CTD
PMID:14712291
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of KPNA2 mRNA
CTD
PMID:17374387
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Krt19
keratin 19
decreases expression
ISO
Cytarabine results in decreased expression of KRT19 mRNA
CTD
PMID:21198554
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt24
keratin 24
decreases expression
ISO
Cytarabine results in decreased expression of KRT24 mRNA
CTD
PMID:21198554
NCBI chr10:84,232,163...84,237,299
Ensembl chr10:84,232,164...84,237,299
G
Krt8
keratin 8
decreases expression
ISO
Cytarabine results in decreased expression of KRT8 mRNA
CTD
PMID:21198554
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Kynu
kynureninase
decreases expression
ISO
Cytarabine results in decreased expression of KYNU mRNA
CTD
PMID:21198554
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lbh
LBH regulator of WNT signaling pathway
decreases expression
ISO
Cytarabine results in decreased expression of LBH mRNA
CTD
PMID:21198554
NCBI chr 6:22,569,238...22,593,056
Ensembl chr 6:22,568,834...22,593,079
G
Lepr
leptin receptor
decreases expression
ISO
Cytarabine results in decreased expression of LEPR mRNA
CTD
PMID:21198554
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lhfpl6
LHFPL tetraspan subfamily member 6
increases expression
ISO
Cytarabine results in increased expression of LHFPL6 mRNA
CTD
PMID:21198554
NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
Cytarabine results in increased expression of LIMCH1 mRNA
CTD
PMID:21198554
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
G
Lmcd1
LIM and cysteine-rich domains 1
decreases expression
ISO
Cytarabine results in decreased expression of LMCD1 mRNA
CTD
PMID:21198554
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
G
Lox
lysyl oxidase
decreases expression
ISO
Cytarabine results in decreased expression of LOX mRNA
CTD
PMID:21198554
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl4
lysyl oxidase-like 4
decreases expression
ISO
Cytarabine results in decreased expression of LOXL4 mRNA
CTD
PMID:21198554
NCBI chr 1:241,396,183...241,416,385
Ensembl chr 1:241,397,983...241,416,322
G
Lrba
LPS responsive beige-like anchor protein
decreases expression
ISO
Cytarabine results in decreased expression of LRBA mRNA
CTD
PMID:21198554
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
G
Lrfn5
leucine rich repeat and fibronectin type III domain containing 5
decreases expression
ISO
Cytarabine results in decreased expression of LRFN5 mRNA
CTD
PMID:21198554
NCBI chr 6:79,466,403...79,822,821
Ensembl chr 6:79,467,961...79,822,815
G
Lrig1
leucine-rich repeats and immunoglobulin-like domains 1
increases expression
ISO
Cytarabine results in increased expression of LRIG1 mRNA
CTD
PMID:21198554
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
G
Lrp1b
LDL receptor related protein 1B
decreases expression
ISO
Cytarabine results in decreased expression of LRP1B mRNA
CTD
PMID:21198554
NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
G
Lrrc32
leucine rich repeat containing 32
decreases expression
ISO
Cytarabine results in decreased expression of LRRC32 mRNA
CTD
PMID:21198554
NCBI chr 1:152,785,709...152,802,997
Ensembl chr 1:152,786,511...152,798,373
G
Lrrc41
leucine rich repeat containing 41
decreases expression
ISO
Cytarabine results in decreased expression of LRRC41 mRNA
CTD
PMID:21198554
NCBI chr 5:129,554,547...129,575,450
Ensembl chr 5:129,554,547...129,575,449
G
Lrrn2
leucine rich repeat neuronal 2
decreases expression
ISO
Cytarabine results in decreased expression of LRRN2 mRNA
CTD
PMID:21198554
NCBI chr13:44,321,944...44,382,454
Ensembl chr13:44,321,364...44,382,482
G
Lrrn3
leucine rich repeat neuronal 3
increases expression
ISO
Cytarabine results in increased expression of LRRN3 mRNA
CTD
PMID:21198554
NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330
G
Lrrn4
leucine rich repeat neuronal 4
decreases expression
ISO
Cytarabine results in decreased expression of LRRN4 mRNA
CTD
PMID:21198554
NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831
G
Lum
lumican
decreases expression
ISO
Cytarabine results in decreased expression of LUM mRNA
CTD
PMID:21198554
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
G
Ly6h
lymphocyte antigen 6 family member H
decreases expression
ISO
Cytarabine results in decreased expression of LY6H mRNA
CTD
PMID:21198554
NCBI chr 7:107,258,779...107,261,270
Ensembl chr 7:107,258,779...107,261,454
G
Ly75
lymphocyte antigen 75
increases expression
ISO
Cytarabine results in increased expression of LY75 mRNA
CTD
PMID:19194470
NCBI chr 3:44,764,702...44,852,219
Ensembl chr 3:44,765,122...44,852,374
G
Lyl1
LYL1, basic helix-loop-helix family member
decreases response to substance
ISO
LYL1 protein results in decreased susceptibility to Cytarabine
CTD
PMID:16094422
NCBI chr19:23,452,140...23,455,007
Ensembl chr19:23,452,140...23,455,007
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of LYN mRNA
CTD
PMID:21198554
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Lyz2
lysozyme 2
increases expression
ISO
Cytarabine results in increased expression of LYZ mRNA
CTD
PMID:19194470
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Mab21l2
mab-21 like 2
decreases expression
ISO
Cytarabine results in decreased expression of MAB21L2 mRNA
CTD
PMID:21198554
NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
increases expression
ISO
Cytarabine results in increased expression of MAGI1 mRNA
CTD
PMID:21198554
NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
G
Map2
microtubule-associated protein 2
decreases expression increases expression
ISO
Cytarabine results in decreased expression of MAP2 protein Cytarabine results in increased expression of MAP2 mRNA
CTD
PMID:21198554
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Marchf3
membrane associated ring-CH-type finger 3
decreases expression
ISO
Cytarabine results in decreased expression of MARCHF3 mRNA
CTD
PMID:21198554
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
G
Matn2
matrilin 2
decreases expression
ISO
Cytarabine results in decreased expression of MATN2 mRNA
CTD
PMID:21198554
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Mbtd1
mbt domain containing 1
increases expression
ISO
Cytarabine results in increased expression of MBTD1 mRNA
CTD
PMID:21198554
NCBI chr10:78,839,140...78,895,413
Ensembl chr10:78,839,036...78,893,720
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
ISO
Cytarabine results in decreased expression of MCL1 protein
CTD
PMID:16818278
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcoln3
mucolipin TRP cation channel 3
decreases expression
ISO
Cytarabine results in decreased expression of MCOLN3 mRNA
CTD
PMID:21198554
NCBI chr 2:235,008,716...235,042,885
Ensembl chr 2:234,966,010...235,043,047
G
Mdk
midkine
decreases expression
ISO
Cytarabine results in decreased expression of MDK mRNA
CTD
PMID:21198554
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Med9
mediator complex subunit 9
decreases expression
ISO
Cytarabine results in decreased expression of MED9 mRNA
CTD
PMID:19194470
NCBI chr10:44,750,667...44,765,464
Ensembl chr10:44,750,698...44,765,464
G
Megf10
multiple EGF-like domains 10
increases expression
ISO
Cytarabine results in increased expression of MEGF10 mRNA
CTD
PMID:21198554
NCBI chr18:50,605,231...50,755,441
Ensembl chr18:50,605,656...50,754,456
G
Meis1
Meis homeobox 1
increases expression
ISO
Cytarabine results in increased expression of MEIS1 mRNA
CTD
PMID:21198554
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Mertk
MER proto-oncogene, tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of MERTK mRNA
CTD
PMID:21198554
NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554
G
Mfap4
microfibril associated protein 4
decreases expression
ISO
Cytarabine results in decreased expression of MFAP4 mRNA
CTD
PMID:21198554
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
G
Mgarp
mitochondria-localized glutamic acid-rich protein
decreases expression
ISO
Cytarabine results in decreased expression of MGARP mRNA
CTD
PMID:21198554
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
G
Mgp
matrix Gla protein
decreases expression
ISO
Cytarabine results in decreased expression of MGP mRNA
CTD
PMID:21198554
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mindy4
MINDY lysine 48 deubiquitinase 4
decreases expression
ISO
Cytarabine results in decreased expression of MINDY4 mRNA
CTD
PMID:21198554
NCBI chr 4:84,358,660...84,469,189
Ensembl chr 4:84,358,902...84,463,395
G
Mmp23
matrix metallopeptidase 23
decreases expression
ISO
Cytarabine results in decreased expression of MMP23B mRNA
CTD
PMID:21198554
NCBI chr 5:166,239,643...166,242,734
Ensembl chr 5:166,239,644...166,242,433
G
Mpzl1
myelin protein zero-like 1
decreases expression
ISO
Cytarabine results in decreased expression of MPZL1 mRNA
CTD
PMID:21198554
NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616
G
Msx1
msh homeobox 1
decreases expression
ISO
Cytarabine results in decreased expression of MSX1 mRNA
CTD
PMID:21198554
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
G
Mt1
metallothionein 1
decreases expression
ISO
Cytarabine results in decreased expression of MT1A mRNA
CTD
PMID:21198554
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt1-ps3
metallothionein 1, pseudogene 3
decreases expression
ISO
Cytarabine results in decreased expression of MT1E mRNA
CTD
PMID:21198554
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
G
Mt2A
metallothionein 2A
decreases expression
ISO
Cytarabine results in decreased expression of MT2A mRNA
CTD
PMID:21198554
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR protein affects the susceptibility to Cytarabine
CTD
PMID:18202788
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtus1
microtubule associated scaffold protein 1
increases expression
ISO
Cytarabine results in increased expression of MTUS1 mRNA
CTD
PMID:21198554
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
G
Mvb12a
multivesicular body subunit 12A
decreases expression
ISO
Cytarabine results in decreased expression of MVB12A mRNA
CTD
PMID:21198554
NCBI chr16:18,252,227...18,257,111
Ensembl chr16:18,252,222...18,257,539
G
Mxd3
Max dimerization protein 3
increases expression
ISO
Cytarabine results in increased expression of MXD3 mRNA
CTD
PMID:21198554
NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157
G
Mxra7
matrix remodeling associated 7
decreases expression
ISO
Cytarabine results in decreased expression of MXRA7 mRNA
CTD
PMID:21198554
NCBI chr10:102,003,034...102,031,428
Ensembl chr10:102,003,319...102,031,409
G
Myadm
myeloid-associated differentiation marker
decreases expression
ISO
Cytarabine results in decreased expression of MYADM mRNA
CTD
PMID:21198554
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Mydgf
myeloid-derived growth factor
decreases expression
ISO
Cytarabine results in decreased expression of MYDGF mRNA
CTD
PMID:21198554
NCBI chr 9:999,659...1,008,804
Ensembl chr 9:1,000,722...1,008,822
G
Myl4
myosin, light chain 4
decreases expression
ISO
Cytarabine results in decreased expression of MYL4 mRNA
CTD
PMID:21198554
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
G
Myl7
myosin light chain 7
decreases expression
ISO
Cytarabine results in decreased expression of MYL7 mRNA
CTD
PMID:21198554
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
G
Mylip
myosin regulatory light chain interacting protein
decreases expression
ISO
Cytarabine results in decreased expression of MYLIP mRNA
CTD
PMID:21198554
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
G
Myof
myoferlin
decreases expression
ISO
Cytarabine results in decreased expression of MYOF mRNA
CTD
PMID:21198554
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
G
Nav2
neuron navigator 2
decreases expression
ISO
Cytarabine results in decreased expression of NAV2 mRNA
CTD
PMID:21198554
NCBI chr 1:98,957,629...99,322,339
Ensembl chr 1:98,663,759...99,322,337
G
Ncald
neurocalcin delta
increases expression
ISO
Cytarabine results in increased expression of NCALD mRNA
CTD
PMID:21198554
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
G
Ndc80
NDC80 kinetochore complex component
increases expression
ISO
Cytarabine results in increased expression of NDC80 mRNA
CTD
PMID:19194470
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndrg1
N-myc downstream regulated 1
decreases expression
ISO
Cytarabine results in decreased expression of NDRG1 mRNA
CTD
PMID:21198554
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg2
NDRG family member 2
decreases expression
ISO
Cytarabine results in decreased expression of NDRG2 mRNA
CTD
PMID:21198554
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
G
Nell2
neural EGFL like 2
increases expression
ISO
Cytarabine results in increased expression of NELL2 mRNA
CTD
PMID:21198554
NCBI chr 7:126,343,089...126,662,903
Ensembl chr 7:126,198,851...126,733,503
G
Nes
nestin
increases expression decreases expression
ISO
Cytarabine results in increased expression of NES mRNA Cytarabine results in decreased expression of NES protein
CTD
PMID:21198554
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nfib
nuclear factor I/B
increases expression
ISO
Cytarabine results in increased expression of NFIB mRNA
CTD
PMID:21198554
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Nherf1
NHERF family PDZ scaffold protein 1
decreases expression
ISO
Cytarabine results in decreased expression of NHERF1 mRNA
CTD
PMID:21198554
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
G
Niban2
niban apoptosis regulator 2
decreases expression
ISO
Cytarabine results in decreased expression of NIBAN2 mRNA
CTD
PMID:21198554
NCBI chr 3:16,174,674...16,224,293
Ensembl chr 3:16,174,659...16,224,293
G
Nmu
neuromedin U
increases expression
ISO
Cytarabine results in increased expression of NMU mRNA
CTD
PMID:21198554
NCBI chr14:31,844,564...31,872,196
Ensembl chr14:31,844,728...31,872,192
G
Nova1
NOVA alternative splicing regulator 1
increases expression
ISO
Cytarabine results in increased expression of NOVA1 mRNA
CTD
PMID:21198554
NCBI chr 6:63,780,105...63,905,567
Ensembl chr 6:63,783,489...63,906,289
G
Nox4
NADPH oxidase 4
decreases expression
ISO
Cytarabine results in decreased expression of NOX4 mRNA
CTD
PMID:21198554
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nppb
natriuretic peptide B
increases expression
ISO
Cytarabine results in increased expression of NPPB mRNA; Cytarabine results in increased expression of NPPB protein
CTD
PMID:16151589 PMID:21198554
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Npy
neuropeptide Y
decreases expression
ISO
Cytarabine results in decreased expression of NPY mRNA
CTD
PMID:21198554
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nrip3
nuclear receptor interacting protein 3
decreases expression
ISO
Cytarabine results in decreased expression of NRIP3 mRNA
CTD
PMID:21198554
NCBI chr 1:163,789,738...163,815,036
Ensembl chr 1:163,789,738...163,815,600
G
Nrp1
neuropilin 1
multiple interactions
ISO
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA
CTD
PMID:23264188
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Ntm
neurotrimin
decreases expression
ISO
Cytarabine results in decreased expression of NTM mRNA
CTD
PMID:21198554
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
G
Ntng1
netrin G1
increases expression
ISO
Cytarabine results in increased expression of NTNG1 mRNA
CTD
PMID:21198554
NCBI chr 2:197,462,785...197,827,681
Ensembl chr 2:197,463,945...197,826,997
G
Odam
odontogenic, ameloblast associated
decreases expression
ISO
Cytarabine results in decreased expression of ODAM mRNA
CTD
PMID:21198554
NCBI chr14:20,193,286...20,202,517
Ensembl chr14:20,193,302...20,202,517
G
Olfml3
olfactomedin-like 3
decreases expression
ISO
Cytarabine results in decreased expression of OLFML3 mRNA
CTD
PMID:21198554
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
G
Olr1
oxidized low density lipoprotein receptor 1
decreases expression
ISO
Cytarabine results in decreased expression of OLR1 mRNA
CTD
PMID:21198554
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Osbpl10
oxysterol binding protein-like 10
decreases expression
ISO
Cytarabine results in decreased expression of OSBPL10 mRNA
CTD
PMID:21198554
NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625
G
Osr1
odd-skipped related transcription factor 1
decreases expression
ISO
Cytarabine results in decreased expression of OSR1 mRNA
CTD
PMID:21198554
NCBI chr 6:32,369,561...32,380,822
Ensembl chr 6:32,373,816...32,380,817
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of P4HA2 mRNA
CTD
PMID:21198554
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,243,139...38,287,314
G
Pals2
protein associated with LIN7 2, MAGUK p55 family member
decreases expression
ISO
Cytarabine results in decreased expression of PALS2 mRNA
CTD
PMID:21198554
NCBI chr 4:79,173,488...79,257,542
Ensembl chr 4:79,124,806...79,254,140
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
decreases expression
ISO
Cytarabine results in decreased expression of PAMR1 mRNA
CTD
PMID:21198554
NCBI chr 3:88,889,061...88,988,615
Ensembl chr 3:88,889,046...88,988,606
G
Pard6a
par-6 family cell polarity regulator alpha
decreases expression
ISO
Cytarabine results in decreased expression of PARD6A mRNA
CTD
PMID:19194470
NCBI chr19:33,589,531...33,591,900
Ensembl chr19:33,589,542...33,591,900
G
Parm1
prostate androgen-regulated mucin-like protein 1
decreases expression
ISO
Cytarabine results in decreased expression of PARM1 mRNA
CTD
PMID:21198554
NCBI chr14:16,468,309...16,577,339
Ensembl chr14:16,468,459...16,577,314
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases degradation
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]
CTD
PMID:8840993 PMID:12780785
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pax6
paired box 6
increases expression decreases expression
ISO
Cytarabine results in increased expression of PAX6 mRNA Cytarabine results in decreased expression of PAX6 protein
CTD
PMID:21198554
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Pcdh20
protocadherin 20
decreases expression
ISO
Cytarabine results in decreased expression of PCDH20 mRNA
CTD
PMID:21198554
NCBI chr15:64,425,534...64,431,790
Ensembl chr15:64,425,534...64,431,790
G
Pcdh7
protocadherin 7
decreases expression
ISO
Cytarabine results in decreased expression of PCDH7 mRNA
CTD
PMID:21198554
NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051 Ensembl chr14:52,475,610...52,902,051
G
Pced1b
PC-esterase domain containing 1B
decreases expression
ISO
Cytarabine results in decreased expression of PCED1B mRNA
CTD
PMID:21198554
NCBI chr 7:128,394,388...128,528,231
Ensembl chr 7:128,391,319...128,528,231
G
Pcsk5
proprotein convertase subtilisin/kexin type 5
decreases expression
ISO
Cytarabine results in decreased expression of PCSK5 mRNA
CTD
PMID:21198554
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600
G
Pde1a
phosphodiesterase 1A
increases expression
ISO
Cytarabine results in increased expression of PDE1A mRNA
CTD
PMID:21198554
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde1b
phosphodiesterase 1B
increases expression
ISO
Cytarabine results in increased expression of PDE1B mRNA
CTD
PMID:21198554
NCBI chr 7:134,627,378...134,654,581
Ensembl chr 7:134,627,322...134,654,580
G
Pde4b
phosphodiesterase 4B
increases expression
ISO
Cytarabine results in increased expression of PDE4B mRNA
CTD
PMID:21198554
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
G
Pde6d
phosphodiesterase 6D
decreases expression
ISO
Cytarabine results in decreased expression of PDE6D mRNA
CTD
PMID:19194470
NCBI chr 9:87,192,989...87,237,979
Ensembl chr 9:87,192,983...87,237,969
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO
Cytarabine results in decreased expression of PDGFRB mRNA
CTD
PMID:21198554
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdlim3
PDZ and LIM domain 3
increases expression
ISO
Cytarabine results in increased expression of PDLIM3 mRNA
CTD
PMID:21198554
NCBI chr16:46,352,460...46,383,680
Ensembl chr16:46,352,467...46,383,657
G
Pdlim4
PDZ and LIM domain 4
multiple interactions
ISO
Cytarabine inhibits the reaction [decitabine results in increased expression of PDLIM4 mRNA]
CTD
PMID:17634552
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
G
Pdpn
podoplanin
decreases expression
ISO
Cytarabine results in decreased expression of PDPN mRNA
CTD
PMID:21198554
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Peli1
pellino E3 ubiquitin protein ligase 1
increases expression
ISO
Cytarabine results in increased expression of PELI1 mRNA
CTD
PMID:21198554
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285 Ensembl chr 1:95,254,589...95,308,285
G
Pfkp
phosphofructokinase, platelet
decreases expression
ISO
Cytarabine results in decreased expression of PFKP mRNA
CTD
PMID:21198554
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
Cytarabine results in decreased expression of PGM5 mRNA
CTD
PMID:21198554
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Phactr2
phosphatase and actin regulator 2
decreases expression
ISO
Cytarabine results in decreased expression of PHACTR2 mRNA
CTD
PMID:21198554
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
G
Phyhipl
phytanoyl-CoA 2-hydroxylase interacting protein-like
increases expression
ISO
Cytarabine results in increased expression of PHYHIPL mRNA
CTD
PMID:21198554
NCBI chr20:18,024,744...18,065,822
Ensembl chr20:18,024,666...18,065,478
G
Pigh
phosphatidylinositol glycan anchor biosynthesis, class H
decreases expression
ISO
Cytarabine results in decreased expression of PIGH mRNA
CTD
PMID:21198554
NCBI chr 6:97,874,903...97,897,188
Ensembl chr 6:97,882,903...97,897,142
G
Pitx1
paired-like homeodomain 1
decreases expression
ISO
Cytarabine results in decreased expression of PITX1 mRNA
CTD
PMID:21198554
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
G
Pitx2
paired-like homeodomain 2
decreases expression
ISO
Cytarabine results in decreased expression of PITX2 mRNA
CTD
PMID:21198554
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
G
Pkia
cAMP-dependent protein kinase inhibitor alpha
decreases expression
ISO
Cytarabine results in decreased expression of PKIA mRNA
CTD
PMID:21198554
NCBI chr 2:94,398,869...94,473,638
Ensembl chr 2:94,398,869...94,414,282
G
Pkp2
plakophilin 2
decreases expression
ISO
Cytarabine results in decreased expression of PKP2 mRNA
CTD
PMID:21198554
NCBI chr11:84,661,783...84,727,730
Ensembl chr11:84,661,783...84,727,730
G
Plac9
placenta associated 9
decreases expression
ISO
Cytarabine results in decreased expression of PLAC9 mRNA
CTD
PMID:21198554
NCBI chr16:1,459,450...1,474,275
Ensembl chr16:1,459,456...1,474,399
G
Plat
plasminogen activator, tissue type
decreases expression
ISO
Cytarabine results in decreased expression of PLAT mRNA
CTD
PMID:21198554
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plcb2
phospholipase C, beta 2
affects localization multiple interactions
ISO
Cytarabine affects the localization of PLCB2 protein edelfosine inhibits the reaction [Cytarabine affects the localization of PLCB2 protein]
CTD
PMID:9295281
NCBI chr 3:105,683,676...105,704,384
Ensembl chr 3:105,684,815...105,704,302
G
Plch1
phospholipase C, eta 1
increases expression
ISO
Cytarabine results in increased expression of PLCH1 mRNA
CTD
PMID:21198554
NCBI chr 2:148,148,908...148,363,616
Ensembl chr 2:148,148,921...148,364,097
G
Pld3
phospholipase D family, member 3
decreases expression
ISO
Cytarabine results in decreased expression of PLD3 mRNA
CTD
PMID:21198554
NCBI chr 1:82,821,863...82,844,280
Ensembl chr 1:82,821,875...82,844,072
G
Plekhg3
pleckstrin homology and RhoGEF domain containing G3
decreases expression
ISO
Cytarabine results in decreased expression of PLEKHG3 mRNA
CTD
PMID:21198554
NCBI chr 6:95,265,756...95,308,952
Ensembl chr 6:95,266,058...95,310,359
G
Plg
plasminogen
affects localization
ISO
Cytarabine affects the localization of PLG protein
CTD
PMID:12165291
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Plin3
perilipin 3
decreases expression
ISO
Cytarabine results in decreased expression of PLIN3 mRNA
CTD
PMID:21198554
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Pllp
plasmolipin
decreases expression
ISO
Cytarabine results in decreased expression of PLLP mRNA
CTD
PMID:21198554
NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892
G
Plod1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
decreases expression
ISO
Cytarabine results in decreased expression of PLOD1 mRNA
CTD
PMID:21198554
NCBI chr 5:158,340,674...158,367,581
Ensembl chr 5:158,340,490...158,367,620
G
Plp1
proteolipid protein 1
increases expression
ISO
Cytarabine results in increased expression of PLP1 mRNA
CTD
PMID:21198554
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Pltp
phospholipid transfer protein
decreases expression
ISO
Cytarabine results in decreased expression of PLTP mRNA
CTD
PMID:21198554
NCBI chr 3:153,574,825...153,592,647
Ensembl chr 3:153,574,825...153,592,647
G
Pmel
premelanosome protein
increases expression
ISO
Cytarabine results in increased expression of PMEL mRNA
CTD
PMID:21198554
NCBI chr 7:1,138,202...1,148,735
Ensembl chr 7:1,138,586...1,148,746
G
Pmp22
peripheral myelin protein 22
decreases expression
ISO
Cytarabine results in decreased expression of PMP22 mRNA
CTD
PMID:21198554
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
G
Podxl
podocalyxin-like
decreases expression
ISO
Cytarabine results in decreased expression of PODXL mRNA
CTD
PMID:21198554
NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899
G
Podxl2
podocalyxin-like 2
increases expression
ISO
Cytarabine results in increased expression of PODXL2 mRNA
CTD
PMID:21198554
NCBI chr 4:121,306,224...121,338,070
Ensembl chr 4:121,306,224...121,338,112
G
Postn
periostin
decreases expression
ISO
Cytarabine results in decreased expression of POSTN mRNA
CTD
PMID:21198554
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]
CTD
PMID:23264188
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppic
peptidylprolyl isomerase C
decreases expression
ISO
Cytarabine results in decreased expression of PPIC mRNA
CTD
PMID:21198554
NCBI chr18:46,842,410...46,855,016
Ensembl chr18:46,842,409...46,855,017
G
Ppm1m
protein phosphatase, Mg2+/Mn2+ dependent, 1M
decreases expression
ISO
Cytarabine results in decreased expression of PPM1M mRNA
CTD
PMID:21198554
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
G
Ppt2
palmitoyl-protein thioesterase 2
decreases expression
ISO
Cytarabine results in decreased expression of PPT2 mRNA
CTD
PMID:21198554
NCBI chr20:4,112,520...4,132,774
Ensembl chr20:4,122,463...4,132,774
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
Cytarabine results in decreased expression of PRC1 mRNA
CTD
PMID:17374387
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm8
PR/SET domain 8
increases expression
ISO
Cytarabine results in increased expression of PRDM8 mRNA
CTD
PMID:21198554
NCBI chr14:11,403,202...11,424,059
Ensembl chr14:11,404,407...11,410,993
G
Prickle1
prickle planar cell polarity protein 1
decreases expression
ISO
Cytarabine results in decreased expression of PRICKLE1 mRNA
CTD
PMID:21198554
NCBI chr 7:124,639,142...124,735,027
Ensembl chr 7:124,639,142...124,658,113
G
Prkcz
protein kinase C, zeta
decreases response to substance
ISO
PRKCZ protein results in decreased susceptibility to Cytarabine
CTD
PMID:21863889
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Prl
prolactin
increases expression
ISO
Cytarabine results in increased expression of PRL protein
CTD
PMID:8312290
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prnp
prion protein
decreases expression
ISO
Cytarabine results in decreased expression of PRNP mRNA
CTD
PMID:21198554
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Prph
peripherin
decreases expression
ISO
Cytarabine results in decreased expression of PRPH mRNA
CTD
PMID:21198554
NCBI chr 7:130,218,149...130,222,136
Ensembl chr 7:130,218,357...130,222,136
G
Prrc2c
proline-rich coiled-coil 2C
decreases expression
ISO
Cytarabine results in decreased expression of PRRC2C mRNA
CTD
PMID:19194470
NCBI chr13:75,003,995...75,073,701
Ensembl chr13:75,004,010...75,073,643
G
Prss35
serine protease 35
decreases expression
ISO
Cytarabine results in decreased expression of PRSS35 mRNA
CTD
PMID:21198554
NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
Cytarabine results in increased expression of PSD3 mRNA
CTD
PMID:21198554
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psrc1
proline and serine rich coiled-coil 1
decreases expression
ISO
Cytarabine results in decreased expression of PSRC1 mRNA
CTD
PMID:17374387
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
G
Pstpip2
proline-serine-threonine phosphatase-interacting protein 2
decreases expression
ISO
Cytarabine results in decreased expression of PSTPIP2 mRNA
CTD
PMID:19194470
NCBI chr18:71,310,387...71,396,752
Ensembl chr18:71,311,020...71,395,709
G
Pten
phosphatase and tensin homolog
increases response to substance
ISO
PTEN protein results in increased susceptibility to Cytarabine
CTD
PMID:22185283
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
PTGS2 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pth1r
parathyroid hormone 1 receptor
decreases expression
ISO
Cytarabine results in decreased expression of PTH1R mRNA
CTD
PMID:21198554
NCBI chr 8:110,693,910...110,725,458
Ensembl chr 8:110,697,485...110,719,729
G
Ptprz1
protein tyrosine phosphatase, receptor type Z1
increases expression
ISO
Cytarabine results in increased expression of PTPRZ1 mRNA
CTD
PMID:21198554
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
ISO
Cytarabine results in decreased expression of QPRT mRNA
CTD
PMID:21198554
NCBI chr 1:181,718,189...181,733,486
Ensembl chr 1:181,718,190...181,733,486
G
Rab37
RAB37, member RAS oncogene family
decreases expression
ISO
Cytarabine results in decreased expression of RAB37 mRNA
CTD
PMID:21198554
NCBI chr10:100,334,639...100,401,974
Ensembl chr10:100,334,216...100,401,474
G
Rab5b
RAB5B, member RAS oncogene family
increases expression
ISO
Cytarabine results in increased expression of RAB5B mRNA
CTD
PMID:19194470
NCBI chr 7:1,109,449...1,128,348
Ensembl chr 7:1,109,454...1,128,268
G
Rabggtb
Rab geranylgeranyltransferase subunit beta
decreases expression
ISO
Cytarabine results in decreased expression of RABGGTB mRNA
CTD
PMID:19194470
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
Cytarabine results in decreased expression of RAD23A mRNA
CTD
PMID:19194470
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rad51
RAD51 recombinase
increases expression
ISO
Cytarabine results in increased expression of RAD51 mRNA
CTD
PMID:19194470
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Ralgdsl1
ral guanine nucleotide dissociation stimulator like 1
decreases expression
ISO
Cytarabine results in decreased expression of RGL1 mRNA
CTD
PMID:21198554
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
G
Ramp1
receptor activity modifying protein 1
decreases expression
ISO
Cytarabine results in decreased expression of RAMP1 mRNA
CTD
PMID:21198554
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
G
Rassf2
Ras association domain family member 2
increases expression
ISO
Cytarabine results in increased expression of RASSF2 mRNA
CTD
PMID:21198554
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
G
Rbm34
RNA binding motif protein 34
decreases expression
ISO
Cytarabine results in decreased expression of RBM34 mRNA
CTD
PMID:19194470
NCBI chr19:54,936,516...54,956,810
Ensembl chr19:54,936,531...54,956,715
G
Recql5
RecQ like helicase 5
decreases expression
ISO
Cytarabine results in decreased expression of RECQL5 mRNA
CTD
PMID:19194470
NCBI chr10:101,126,544...101,165,739
Ensembl chr10:101,126,547...101,165,652
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases phosphorylation decreases activity
ISO
calyculin A inhibits the reaction [Cytarabine results in decreased activity of RELA protein] Cytarabine results in decreased phosphorylation of RELA protein
CTD
PMID:12853972
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Reln
reelin
decreases expression
ISO
Cytarabine results in decreased expression of RELN mRNA
CTD
PMID:21198554
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
G
Rerg
RAS-like, estrogen-regulated, growth-inhibitor
decreases expression
ISO
Cytarabine results in decreased expression of RERG mRNA
CTD
PMID:21198554
NCBI chr 4:169,981,634...170,089,777
Ensembl chr 4:169,982,279...170,089,715
G
Rexo4
REX4 homolog, 3'-5' exonuclease
decreases expression
ISO
Cytarabine results in decreased expression of REXO4 mRNA
CTD
PMID:21198554
NCBI chr 3:10,280,654...10,291,003
Ensembl chr 3:10,280,654...10,290,996
G
Rgmb
repulsive guidance molecule BMP co-receptor b
increases expression
ISO
Cytarabine results in increased expression of RGMB mRNA
CTD
PMID:21198554
NCBI chr 1:56,766,598...56,792,396
Ensembl chr 1:56,767,850...56,792,425
G
Rgs1
regulator of G-protein signaling 1
decreases expression
ISO
Cytarabine results in decreased expression of RGS1 mRNA
CTD
PMID:21198554
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rgs13
regulator of G-protein signaling 13
decreases expression
ISO
Cytarabine results in decreased expression of RGS13 mRNA
CTD
PMID:21198554
NCBI chr13:55,922,290...55,955,753
Ensembl chr13:55,922,395...55,955,648
G
Rgs20
regulator of G-protein signaling 20
increases expression
ISO
Cytarabine results in increased expression of RGS20 mRNA
CTD
PMID:21198554
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
G
Rgs4
regulator of G-protein signaling 4
decreases expression
ISO
Cytarabine results in decreased expression of RGS4 mRNA
CTD
PMID:21198554
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rhoc
ras homolog family member C
decreases expression
ISO
Cytarabine results in decreased expression of RHOC mRNA
CTD
PMID:21198554
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
decreases expression
ISO
Cytarabine results in decreased expression of RHPN2 mRNA
CTD
PMID:21198554
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rnase2
ribonuclease A family member 2
increases expression
ISO
Cytarabine results in increased expression of RNASE2 mRNA
CTD
PMID:19194470
NCBI chr15:24,449,618...24,450,427
Ensembl chr15:24,449,611...24,450,479
G
Robo3
roundabout guidance receptor 3
increases expression
ISO
Cytarabine results in increased expression of ROBO3 mRNA
CTD
PMID:21198554
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
G
Rpp25
ribonuclease P and MRP subunit p25
decreases expression
ISO
Cytarabine results in decreased expression of RPP25 mRNA
CTD
PMID:21198554
NCBI chr 8:57,907,352...57,908,732
Ensembl chr 8:57,907,352...57,908,732
G
Rprml
reprimo-like
increases expression
ISO
Cytarabine results in increased expression of RPRML mRNA
CTD
PMID:21198554
NCBI chr10:88,560,248...88,561,252
Ensembl chr10:88,560,248...88,561,252
G
Rras
RAS related
decreases expression
ISO
Cytarabine results in decreased expression of RRAS mRNA
CTD
PMID:21198554
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rrm2
ribonucleotide reductase regulatory subunit M2
increases expression
ISO
Cytarabine results in increased expression of RRM2 mRNA
CTD
PMID:19194470
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rspo2
R-spondin 2
decreases expression
ISO
Cytarabine results in decreased expression of RSPO2 mRNA
CTD
PMID:21198554
NCBI chr 7:74,096,378...74,239,398
Ensembl chr 7:74,103,090...74,238,933
G
Rsrp1
arginine and serine rich protein 1
decreases expression
ISO
Cytarabine results in decreased expression of RSRP1 mRNA
CTD
PMID:21198554
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Rtn1
reticulon 1
increases expression
ISO
Cytarabine results in increased expression of RTN1 mRNA
CTD
PMID:21198554
NCBI chr 6:90,763,212...90,983,436
Ensembl chr 6:90,763,216...90,983,436
G
Rwdd1
RWD domain containing 1
increases expression
ISO
Cytarabine results in increased expression of RWDD1 mRNA
CTD
PMID:21198554
NCBI chr20:25,949,723...25,967,147
Ensembl chr20:25,941,966...25,967,193
G
S100a10
S100 calcium binding protein A10
decreases expression
ISO
Cytarabine results in decreased expression of S100A10 mRNA
CTD
PMID:21198554
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
Cytarabine results in decreased expression of S100A4 mRNA
CTD
PMID:21198554
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Saraf
store-operated calcium entry-associated regulatory factor
decreases expression
ISO
Cytarabine results in decreased expression of SARAF mRNA
CTD
PMID:21198554
NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545
G
Sbspon
somatomedin B and thrombospondin, type 1 domain containing
decreases expression
ISO
Cytarabine results in decreased expression of SBSPON mRNA
CTD
PMID:21198554
NCBI chr 5:3,402,763...3,433,338
Ensembl chr 5:3,402,648...3,435,420
G
Scamp5
secretory carrier membrane protein 5
increases expression
ISO
Cytarabine results in increased expression of SCAMP5 mRNA
CTD
PMID:21198554
NCBI chr 8:57,845,831...57,884,516
Ensembl chr 8:57,846,659...57,872,027
G
Scyl1
SCY1 like pseudokinase 1
decreases expression
ISO
Cytarabine results in decreased expression of SCYL1 mRNA
CTD
PMID:21198554
NCBI chr 1:203,045,776...203,059,550
Ensembl chr 1:203,045,741...203,059,533
G
Sdc4
syndecan 4
decreases expression
ISO
Cytarabine results in decreased expression of SDC4 mRNA
CTD
PMID:21198554
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
G
Sec14l1
SEC14-like lipid binding 1
decreases expression
ISO
Cytarabine results in decreased expression of SEC14L1 mRNA
CTD
PMID:21198554
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
G
Selenom
selenoprotein M
decreases expression
ISO
Cytarabine results in decreased expression of SELENOM mRNA
CTD
PMID:21198554
NCBI chr14:78,395,826...78,398,429
Ensembl chr14:78,395,826...78,398,429
G
Sema5b
semaphorin 5B
increases expression
ISO
Cytarabine results in increased expression of SEMA5B mRNA
CTD
PMID:21198554
NCBI chr11:65,102,532...65,225,456
Ensembl chr11:65,102,031...65,225,311
G
Serpina1
serpin family A member 1
increases expression
ISO
Cytarabine results in increased expression of SERPINA1 mRNA
CTD
PMID:19194470
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpinb6a
serpin family B member 6A
decreases expression
ISO
Cytarabine results in decreased expression of SERPINB6 mRNA
CTD
PMID:21198554
NCBI chr17:30,871,468...30,989,703
Ensembl chr17:30,871,468...31,014,427
G
Serpinb9
serpin family B member 9
decreases expression
ISO
Cytarabine results in decreased expression of SERPINB9 mRNA
CTD
PMID:21198554
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpinh1
serpin family H member 1
decreases expression
ISO
Cytarabine results in decreased expression of SERPINH1 mRNA
CTD
PMID:21198554
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Sertad1
SERTA domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SERTAD1 mRNA
CTD
PMID:21198554
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
G
Sesn3
sestrin 3
decreases expression
ISO
Cytarabine results in decreased expression of SESN3 mRNA
CTD
PMID:33770205
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Sfn
stratifin
decreases response to substance
ISO
SFN protein results in decreased susceptibility to Cytarabine
CTD
PMID:25189999
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sfrp1
secreted frizzled-related protein 1
increases expression
ISO
Cytarabine results in increased expression of SFRP1 mRNA
CTD
PMID:21198554
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sfrp2
secreted frizzled-related protein 2
increases expression
ISO
Cytarabine results in increased expression of SFRP2 mRNA
CTD
PMID:21198554
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
G
Sgip1
SH3GL interacting endocytic adaptor 1
increases expression
ISO
Cytarabine results in increased expression of SGIP1 mRNA
CTD
PMID:21198554
NCBI chr 5:117,536,752...117,734,593
Ensembl chr 5:117,537,746...117,734,575
G
Sh3rf2
SH3 domain containing ring finger 2
decreases expression
ISO
Cytarabine results in decreased expression of SH3RF2 mRNA
CTD
PMID:21198554
NCBI chr18:34,045,715...34,148,342
Ensembl chr18:34,046,879...34,146,856
G
Sipa1l2
signal-induced proliferation-associated 1 like 2
decreases expression
ISO
Cytarabine results in decreased expression of SIPA1L2 mRNA
CTD
PMID:21198554
NCBI chr19:53,389,792...53,540,466
Ensembl chr19:53,389,805...53,540,428
G
Sla
src-like adaptor
increases expression
ISO
Cytarabine results in increased expression of SLA mRNA
CTD
PMID:19194470
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
G
Slc12a6
solute carrier family 12, member 6
decreases expression
ISO
Cytarabine results in decreased expression of SLC12A6 mRNA
CTD
PMID:33770205
NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258
G
Slc16a3
solute carrier family 16 member 3
decreases expression
ISO
Cytarabine results in decreased expression of SLC16A3 mRNA
CTD
PMID:21198554
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
G
Slc16a9
solute carrier family 16, member 9
increases expression
ISO
Cytarabine results in increased expression of SLC16A9 mRNA
CTD
PMID:21198554
NCBI chr20:18,335,862...18,377,125
Ensembl chr20:18,335,862...18,377,022
G
Slc17a6
solute carrier family 17 member 6
increases expression
ISO
Cytarabine results in increased expression of SLC17A6 mRNA
CTD
PMID:21198554
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
G
Slc28a1
solute carrier family 28 member 1
multiple interactions
ISO EXP
Cytarabine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine] Cytarabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]
CTD
PMID:8713072 PMID:10772724
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
G
Slc29a1
solute carrier family 29 member 1
decreases response to substance
ISO
SLC29A1 gene polymorphism results in decreased susceptibility to Cytarabine
CTD
PMID:18381442
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a1
solute carrier family 2 member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC2A1 mRNA
CTD
PMID:21198554
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc39a2
solute carrier family 39 member 2
decreases expression
ISO
Cytarabine results in decreased expression of SLC39A2 mRNA
CTD
PMID:21198554
NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850
G
Slc40a1
solute carrier family 40 member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC40A1 mRNA
CTD
PMID:21198554
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
G
Slc43a3
solute carrier family 43, member 3
increases expression
ISO
Cytarabine results in increased expression of SLC43A3 mRNA
CTD
PMID:19194470
NCBI chr 3:70,008,160...70,030,324
Ensembl chr 3:70,009,313...70,029,749
G
Slc47a1
solute carrier family 47 member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC47A1 mRNA
CTD
PMID:21198554
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
G
Slc4a8
solute carrier family 4 member 8
decreases expression
ISO
Cytarabine results in decreased expression of SLC4A8 mRNA
CTD
PMID:21198554
NCBI chr 7:131,861,284...131,939,295
Ensembl chr 7:131,864,102...131,931,051
G
Slc5a12
solute carrier family 5 member 12
decreases expression
ISO
Cytarabine results in decreased expression of SLC5A12 mRNA
CTD
PMID:21198554
NCBI chr 3:97,179,326...97,228,405
Ensembl chr 3:97,179,326...97,228,405
G
Slc7a2
solute carrier family 7 member 2
decreases expression
ISO
Cytarabine results in decreased expression of SLC7A2 mRNA
CTD
PMID:21198554
NCBI chr16:51,417,478...51,470,784
Ensembl chr16:51,417,493...51,470,784
G
Slc7a7
solute carrier family 7 member 7
decreases expression
ISO
Cytarabine results in decreased expression of SLC7A7 mRNA
CTD
PMID:21198554
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slfn9
schlafen family member 9
increases expression
ISO
Cytarabine results in increased expression of SLFN11 mRNA
CTD
PMID:21198554
NCBI chr10:67,909,105...67,955,912
Ensembl chr10:67,909,106...67,925,383
G
Slit2
slit guidance ligand 2
decreases expression
ISO
Cytarabine results in decreased expression of SLIT2 mRNA
CTD
PMID:21198554
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Slitrk3
SLIT and NTRK-like family, member 3
decreases expression
ISO
Cytarabine results in decreased expression of SLITRK3 mRNA
CTD
PMID:21198554
NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709
G
Slitrk5
SLIT and NTRK-like family, member 5
decreases expression
ISO
Cytarabine results in decreased expression of SLITRK5 mRNA
CTD
PMID:19194470
NCBI chr15:88,848,123...88,858,809
Ensembl chr15:88,847,535...88,856,836
G
Sln
sarcolipin
decreases expression
ISO
Cytarabine results in decreased expression of SLN mRNA
CTD
PMID:21198554
NCBI chr 8:54,221,389...54,248,110
Ensembl chr 8:54,243,542...54,247,791
G
Smad6
SMAD family member 6
decreases expression
ISO
Cytarabine results in decreased expression of SMAD6 mRNA
CTD
PMID:21198554
NCBI chr 8:64,450,114...64,519,673
Ensembl chr 8:64,450,114...64,519,763
G
Smoc2
SPARC related modular calcium binding 2
decreases expression
ISO
Cytarabine results in decreased expression of SMOC2 mRNA
CTD
PMID:21198554
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
decreases expression
ISO
Cytarabine results in decreased expression of SMPDL3A mRNA
CTD
PMID:21198554
NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567
G
Snai2
snail family transcriptional repressor 2
decreases expression
ISO
Cytarabine results in decreased expression of SNAI2 mRNA
CTD
PMID:21198554
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snap91
synaptosome associated protein 91
increases expression
ISO
Cytarabine results in increased expression of SNAP91 mRNA
CTD
PMID:21198554
NCBI chr 8:87,738,056...87,852,690
Ensembl chr 8:87,738,824...87,852,367
G
Snca
synuclein alpha
multiple interactions
ISO
Cytarabine promotes the reaction [SNCA protein mutant form results in increased susceptibility to ferrous chloride]; Cytarabine promotes the reaction [SNCA protein mutant form results in increased susceptibility to Iron]
CTD
PMID:14535945
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Snd1
staphylococcal nuclease and tudor domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SND1 mRNA
CTD
PMID:21198554
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
G
Snf8
SNF8 subunit of ESCRT-II
decreases expression
ISO
Cytarabine results in decreased expression of SNF8 mRNA
CTD
PMID:21198554
NCBI chr10:80,984,337...80,996,724
Ensembl chr10:80,984,363...80,996,734
G
Sorbs2
sorbin and SH3 domain containing 2
increases expression
ISO
Cytarabine results in increased expression of SORBS2 mRNA
CTD
PMID:21198554
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
G
Sox21
SRY-box transcription factor 21
increases expression
ISO
Cytarabine results in increased expression of SOX21 mRNA
CTD
PMID:21198554
NCBI chr15:95,292,429...95,296,024
Ensembl chr15:95,292,265...95,296,091
G
Sox3
SRY-box transcription factor 3
increases expression
ISO
Cytarabine results in increased expression of SOX3 mRNA
CTD
PMID:21198554
NCBI chr X:139,308,608...139,310,687
Ensembl chr X:139,309,329...139,310,678
G
Spag16
sperm associated antigen 16
increases expression
ISO
Cytarabine results in increased expression of SPAG16 mRNA
CTD
PMID:21198554
NCBI chr 9:71,333,005...72,252,772
Ensembl chr 9:71,332,992...72,252,708
G
Sparc
secreted protein acidic and cysteine rich
decreases expression
ISO
Cytarabine results in decreased expression of SPARC mRNA
CTD
PMID:21198554
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Spata7
spermatogenesis associated 7
increases expression
ISO
Cytarabine results in increased expression of SPATA7 mRNA
CTD
PMID:21198554
NCBI chr 6:117,879,828...117,925,284
Ensembl chr 6:117,879,823...117,925,284
G
Spin4
spindlin family, member 4
decreases expression
ISO
Cytarabine results in decreased expression of SPIN4 mRNA
CTD
PMID:21198554
NCBI chr X:59,888,728...59,892,817
Ensembl chr X:59,891,581...59,892,330
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
ISO
Cytarabine results in increased expression of SPINK1 mRNA
CTD
PMID:21198554
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Spon1
spondin 1
decreases expression
ISO
Cytarabine results in decreased expression of SPON1 mRNA
CTD
PMID:21198554
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
ISO
Cytarabine results in decreased expression of SPTLC3 mRNA
CTD
PMID:21198554
NCBI chr 3:126,847,878...126,978,010
Ensembl chr 3:126,847,878...126,978,010
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
Cytarabine results in increased expression of SRGAP3 mRNA
CTD
PMID:21198554 PMID:33770205
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575
G
Srgn
serglycin
increases expression
ISO
Cytarabine results in increased expression of SRGN mRNA
CTD
PMID:19194470
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Cytarabine results in increased expression of SRXN1 mRNA
CTD
PMID:22003191
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ssuh2
ssu-2 homolog
increases expression
ISO
Cytarabine results in increased expression of SSUH2 mRNA
CTD
PMID:21198554
NCBI chr 4:145,502,942...145,521,881
Ensembl chr 4:145,503,185...145,521,735
G
St18
ST18 C2H2C-type zinc finger transcription factor
increases expression
ISO
Cytarabine results in increased expression of ST18 mRNA
CTD
PMID:21198554
NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL1 mRNA
CTD
PMID:21198554
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St3gal5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL5 mRNA
CTD
PMID:33770205
NCBI chr 4:104,134,613...104,192,558
Ensembl chr 4:104,134,613...104,192,558
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL6 mRNA
CTD
PMID:21198554
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
St6galnac3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
decreases expression
ISO
Cytarabine results in decreased expression of ST6GALNAC3 mRNA
CTD
PMID:21198554
NCBI chr 2:242,129,755...242,645,120
Ensembl chr 2:242,129,763...242,645,133
G
St6galnac6
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
decreases expression
ISO
Cytarabine results in decreased expression of ST6GALNAC6 mRNA
CTD
PMID:21198554
NCBI chr 3:15,894,275...15,907,502
Ensembl chr 3:15,885,968...15,907,496
G
Stmn4
stathmin 4
increases response to substance
ISO
STMN4 results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr15:40,541,305...40,559,253
Ensembl chr15:40,541,357...40,559,253
G
Stom
stomatin
decreases expression
ISO
Cytarabine results in decreased expression of STOM mRNA
CTD
PMID:21198554
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
G
Ston1
stonin 1
decreases expression
ISO
Cytarabine results in decreased expression of STON1 mRNA
CTD
PMID:21198554
NCBI chr 6:5,843,186...5,892,557
Ensembl chr 6:5,843,185...5,892,449
G
Surf4
surfeit 4
decreases expression
ISO
Cytarabine results in decreased expression of SURF4 mRNA
CTD
PMID:21198554
NCBI chr 3:10,248,360...10,261,537
Ensembl chr 3:10,241,837...10,263,315
G
Svep1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SVEP1 mRNA
CTD
PMID:21198554
NCBI chr 5:72,811,200...72,988,185
Ensembl chr 5:72,811,410...72,988,525
G
Sytl2
synaptotagmin-like 2
increases expression
ISO
Cytarabine results in increased expression of SYTL2 mRNA
CTD
PMID:21198554
NCBI chr 1:144,272,870...144,379,310
Ensembl chr 1:144,273,360...144,379,222
G
Tac1
tachykinin, precursor 1
increases expression
ISO
Cytarabine results in increased expression of TAC1 mRNA
CTD
PMID:21198554
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tac3
tachykinin precursor 3
decreases expression
ISO
Cytarabine results in decreased expression of TAC3 mRNA
CTD
PMID:21198554
NCBI chr 7:63,562,552...63,569,170
Ensembl chr 7:63,562,552...63,569,170
G
Tagln
transgelin
increases expression
ISO
Cytarabine results in increased expression of TAGLN mRNA
CTD
PMID:21198554
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tbc1d4
TBC1 domain family, member 4
decreases expression
ISO
Cytarabine results in decreased expression of TBC1D4 mRNA
CTD
PMID:21198554
NCBI chr15:78,256,030...78,434,168
Ensembl chr15:78,257,121...78,434,265
G
Tceal7
transcription elongation factor A like 7
increases expression
ISO
Cytarabine results in increased expression of TCEAL7 mRNA
CTD
PMID:21198554
NCBI chr X:99,228,405...99,230,551
Ensembl chr X:99,228,458...99,230,543
G
Tcf12
transcription factor 12
increases expression
ISO
Cytarabine results in increased expression of TCF12 mRNA
CTD
PMID:21198554
NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201
G
Tcf21
transcription factor 21
decreases expression
ISO
Cytarabine results in decreased expression of TCF21 mRNA
CTD
PMID:21198554
NCBI chr 1:22,701,353...22,704,212
Ensembl chr 1:22,701,353...22,704,202
G
Tcf25
transcription factor 25
decreases expression
ISO
Cytarabine results in decreased expression of TCF25 mRNA
CTD
PMID:21198554
NCBI chr19:51,415,341...51,449,725
Ensembl chr19:51,415,543...51,449,723
G
Tecrl
trans-2,3-enoyl-CoA reductase-like
decreases expression
ISO
Cytarabine results in decreased expression of TECRL mRNA
CTD
PMID:21198554
NCBI chr14:24,732,241...24,805,272
Ensembl chr14:24,732,241...24,805,272
G
Tek
TEK receptor tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of TEK mRNA
CTD
PMID:21198554
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tent5a
terminal nucleotidyltransferase 5A
decreases expression
ISO
Cytarabine results in decreased expression of TENT5A mRNA
CTD
PMID:21198554
NCBI chr 8:86,222,294...86,229,045
Ensembl chr 8:86,225,357...86,229,045
G
Tent5c
terminal nucleotidyltransferase 5C
decreases expression
ISO
Cytarabine results in decreased expression of TENT5C mRNA
CTD
PMID:21198554
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
G
Tfap2a
transcription factor AP-2 alpha
multiple interactions increases expression
ISO
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of TFAP2A mRNA]
CTD
PMID:23264188
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tfe3
transcription factor binding to IGHM enhancer 3
increases expression
ISO
Cytarabine results in increased expression of TFE3 mRNA
CTD
PMID:19194470
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
G
Tff3
trefoil factor 3
increases expression
ISO
Cytarabine results in increased expression of TFF3 mRNA
CTD
PMID:21198554
NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054
G
Tfpi
tissue factor pathway inhibitor
decreases expression
ISO
Cytarabine results in decreased expression of TFPI mRNA
CTD
PMID:21198554
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Tgfbr3
transforming growth factor beta receptor 3
decreases expression
ISO
Cytarabine results in decreased expression of TGFBR3 mRNA
CTD
PMID:21198554
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
G
Th
tyrosine hydroxylase
decreases expression
ISO
Cytarabine results in decreased expression of TH protein
CTD
PMID:21198554
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Thbs1
thrombospondin 1
increases expression
ISO
Cytarabine results in increased expression of THBS1 mRNA
CTD
PMID:21198554
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thy1
Thy-1 cell surface antigen
decreases expression
ISO
Cytarabine results in decreased expression of THY1 mRNA
CTD
PMID:19194470
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
G
Timp1
TIMP metallopeptidase inhibitor 1
decreases expression
ISO
Cytarabine results in decreased expression of TIMP1 mRNA
CTD
PMID:21198554
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp3
TIMP metallopeptidase inhibitor 3
affects response to substance decreases response to substance
ISO
TIMP3 protein affects the susceptibility to Cytarabine TIMP3 gene modified form results in decreased susceptibility to Cytarabine
CTD
PMID:18202788
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tk1
thymidine kinase 1
decreases activity decreases expression
ISO
Cytarabine results in decreased activity of TK1 protein Cytarabine results in decreased expression of TK1 mRNA
CTD
PMID:12893260
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tk2
thymidine kinase 2
decreases expression decreases activity
ISO
Cytarabine results in decreased expression of TK2 mRNA Cytarabine results in decreased activity of TK2 protein
CTD
PMID:12893260
NCBI chr19:708,859...731,786
Ensembl chr19:708,891...730,924
G
Tln2
talin 2
decreases expression
ISO
Cytarabine results in decreased expression of TLN2 mRNA
CTD
PMID:21198554
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tmed1
transmembrane p24 trafficking protein 1
decreases expression
ISO
Cytarabine results in decreased expression of TMED1 mRNA
CTD
PMID:21198554
NCBI chr 8:20,059,937...20,063,567
Ensembl chr 8:20,059,892...20,063,677
G
Tmed9
transmembrane p24 trafficking protein 9
decreases expression
ISO
Cytarabine results in decreased expression of TMED9 mRNA
CTD
PMID:21198554
NCBI chr17:9,029,646...9,034,160
Ensembl chr17:9,029,646...9,034,176
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
Cytarabine results in decreased expression of TMEM200A mRNA
CTD
PMID:21198554
NCBI chr 1:19,323,646...19,408,324
Ensembl chr 1:19,323,829...19,406,453
G
Tmem45a
transmembrane protein 45A
decreases expression
ISO
Cytarabine results in decreased expression of TMEM45A mRNA
CTD
PMID:21198554
NCBI chr11:43,713,309...43,799,526
Ensembl chr11:43,713,782...43,799,526
G
Tmem62
transmembrane protein 62
increases expression
ISO
Cytarabine results in increased expression of TMEM62 mRNA
CTD
PMID:21198554
NCBI chr 3:107,921,940...107,961,830
Ensembl chr 3:107,927,307...107,961,795
G
Tmem88
transmembrane protein 88
decreases expression
ISO
Cytarabine results in decreased expression of TMEM88 mRNA
CTD
PMID:21198554
NCBI chr10:54,118,752...54,120,447
Ensembl chr10:54,118,752...54,120,447
G
Tmem98
transmembrane protein 98
decreases expression
ISO
Cytarabine results in decreased expression of TMEM98 mRNA
CTD
PMID:21198554
NCBI chr10:65,796,173...65,807,082
Ensembl chr10:65,796,145...65,807,079
G
Tnf
tumor necrosis factor
increases expression
ISO
Cytarabine results in increased expression of TNF protein
CTD
PMID:8318674 PMID:11745875
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
decreases expression
ISO
Cytarabine results in decreased expression of TNFAIP3 mRNA
CTD
PMID:21198554
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf19
TNF receptor superfamily member 19
decreases expression
ISO
Cytarabine results in decreased expression of TNFRSF19 mRNA
CTD
PMID:33770205
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfsf10
TNF superfamily member 10
multiple interactions increases expression
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased expression of BID protein; Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Cytarabine promotes the reaction [TNFSF10 protein results in increased expression of TNFRSF10B protein] Cytarabine results in increased expression of TNFSF10 mRNA
CTD
PMID:12780785 PMID:18549619 PMID:19194470
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnnt2
troponin T2, cardiac type
decreases expression
ISO
Cytarabine results in decreased expression of TNNT2 mRNA
CTD
PMID:21198554
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tnrc6a
trinucleotide repeat containing adaptor 6A
increases expression
ISO
Cytarabine results in increased expression of TNRC6A mRNA
CTD
PMID:21198554
NCBI chr 1:177,561,898...177,715,669
Ensembl chr 1:177,646,030...177,715,660
G
Tp53
tumor protein p53
multiple interactions affects activity increases activity affects response to substance increases response to substance increases expression increases phosphorylation
ISO EXP
[fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein; Caffeine inhibits the reaction [Cytarabine results in increased expression of TP53 protein]; Caffeine inhibits the reaction [Cytarabine results in increased phosphorylation of TP53 protein] Cytarabine affects the activity of TP53 protein; Cytarabine metabolite affects the activity of TP53 protein Cytarabine results in increased activity of TP53 protein TRP53 protein affects the susceptibility to Cytarabine TP53 gene mutant form results in increased susceptibility to Cytarabine [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein; Cytarabine results in increased expression of TP53 protein
CTD
PMID:9703875 PMID:9880587 PMID:10200513 PMID:12082016 PMID:12781215 PMID:14766721 PMID:15203180 PMID:17977830 PMID:19628630 PMID:20477944 PMID:22010212 PMID:22212197 PMID:24675086 PMID:35435491 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i11
tumor protein p53 inducible protein 11
increases response to substance
ISO
TP53I11 results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050
G
Tpk1
thiamin pyrophosphokinase 1
decreases expression
ISO
Cytarabine results in decreased expression of TPK1 mRNA
CTD
PMID:21198554
NCBI chr 4:72,170,134...72,557,707
Ensembl chr 4:72,170,134...72,557,694
G
Tpst1
tyrosylprotein sulfotransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of TPST1 mRNA
CTD
PMID:21198554
NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704
G
Trim5
tripartite motif-containing 5
decreases expression
ISO
Cytarabine results in decreased expression of TRIM5 mRNA
CTD
PMID:21198554
NCBI chr 1:158,720,407...158,737,393
Ensembl chr 1:158,720,410...158,814,012
G
Trim6
tripartite motif containing 6
decreases expression
ISO
Cytarabine results in decreased expression of TRIM6 mRNA
CTD
PMID:21198554
NCBI chr 1:158,683,746...158,696,936
Ensembl chr 1:158,683,746...158,696,914
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
affects localization
ISO
Cytarabine affects the localization of TRPV1 protein
CTD
PMID:18414789
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
decreases expression
ISO
Cytarabine results in decreased expression of TRPV2 mRNA
CTD
PMID:21198554
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Tspan4
tetraspanin 4
decreases expression
ISO
Cytarabine results in decreased expression of TSPAN4 mRNA
CTD
PMID:21198554
NCBI chr 1:196,571,307...196,593,842
Ensembl chr 1:196,572,228...196,617,448
G
Tspo
translocator protein
decreases expression
ISO
Cytarabine results in decreased expression of TSPO mRNA
CTD
PMID:21198554
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
Cytarabine results in decreased expression of TST mRNA
CTD
PMID:21198554
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Ttyh1
tweety family member 1
increases expression
ISO
Cytarabine results in increased expression of TTYH1 mRNA
CTD
PMID:21198554
NCBI chr 1:70,053,312...70,071,872
Ensembl chr 1:70,053,324...70,071,845
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Cytarabine results in decreased expression of TUBB3 protein
CTD
PMID:21198554
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tyms
thymidylate synthetase
affects response to substance increases activity
ISO
TYMS gene polymorphism affects the susceptibility to Cytarabine Cytarabine results in increased activity of TYMS protein
CTD
PMID:15713801 PMID:15816533
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
U2af1
U2 small nuclear RNA auxiliary factor 1
decreases expression
ISO
Cytarabine results in decreased expression of U2AF1 mRNA
CTD
PMID:21198554
NCBI chr20:9,742,904...9,753,840
Ensembl chr20:9,742,905...9,753,832
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Cytarabine results in decreased expression of UBE2C mRNA
CTD
PMID:17374387
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ubl3
ubiquitin-like 3
increases expression
ISO
Cytarabine results in increased expression of UBL3 mRNA
CTD
PMID:19194470
NCBI chr12:6,473,684...6,518,331
Ensembl chr12:6,473,460...6,518,862
G
Usp7
ubiquitin specific peptidase 7
decreases expression
ISO
Cytarabine results in decreased expression of USP7 mRNA
CTD
PMID:19194470
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
G
Vasn
vasorin
decreases expression
ISO
Cytarabine results in decreased expression of VASN mRNA
CTD
PMID:21198554
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Cytarabine results in increased expression of VCAM1 mRNA
CTD
PMID:21198554
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vdr
vitamin D receptor
affects response to substance
ISO
VDR gene polymorphism affects the susceptibility to Cytarabine
CTD
PMID:15713801
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfc
vascular endothelial growth factor C
multiple interactions decreases response to substance
ISO
EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]; PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] EDN1 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]; PTGS2 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vezf1
vascular endothelial zinc finger 1
increases expression
ISO
Cytarabine results in increased expression of VEZF1 mRNA
CTD
PMID:19194470
NCBI chr10:72,859,669...72,876,111
Ensembl chr10:72,859,877...72,876,111
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
Cytarabine results in decreased expression of VGLL4 mRNA
CTD
PMID:21198554
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vrk2
VRK serine/threonine kinase 2
decreases expression
ISO
Cytarabine results in decreased expression of VRK2 mRNA
CTD
PMID:21198554
NCBI chr14:100,313,771...100,434,520
Ensembl chr14:100,313,601...100,434,527
G
Wfdc3
WAP four-disulfide core domain 3
decreases expression
ISO
Cytarabine results in decreased expression of WFDC3 mRNA
CTD
PMID:21198554
NCBI chr 3:153,464,862...153,478,952
Ensembl chr 3:153,464,862...153,478,952
G
Wipf1
WAS/WASL interacting protein family, member 1
decreases expression
ISO
Cytarabine results in decreased expression of WIPF1 mRNA
CTD
PMID:21198554
NCBI chr 3:58,314,521...58,416,668
Ensembl chr 3:58,314,542...58,372,742
G
Xiap
X-linked inhibitor of apoptosis
increases response to substance
ISO
XIAP protein results in increased susceptibility to Cytarabine
CTD
PMID:10815900
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xrcc1
X-ray repair cross complementing 1
increases expression
ISO
Cytarabine results in increased expression of XRCC1 mRNA
CTD
PMID:19194470
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Yif1a
Yip1 interacting factor homolog A, membrane trafficking protein
decreases expression
ISO
Cytarabine results in decreased expression of YIF1A mRNA
CTD
PMID:21198554
NCBI chr 1:202,394,923...202,399,125
Ensembl chr 1:202,394,897...202,399,427
G
Zc3hav1
zinc finger CCCH-type containing, antiviral 1
decreases expression
ISO
Cytarabine results in decreased expression of ZC3HAV1 mRNA
CTD
PMID:21198554
NCBI chr 4:67,012,129...67,062,428
Ensembl chr 4:67,012,185...67,062,428
G
Zfhx4
zinc finger homeobox 4
increases expression
ISO
Cytarabine results in increased expression of ZFHX4 mRNA
CTD
PMID:21198554
NCBI chr 2:96,224,763...96,408,245
Ensembl chr 2:96,224,767...96,408,228
G
Zfp282
zinc finger protein 282
increases expression
ISO
Cytarabine results in increased expression of ZNF282 mRNA
CTD
PMID:33770205
NCBI chr 4:76,884,996...76,910,250
Ensembl chr 4:76,884,924...76,911,370
G
Zfp423
zinc finger protein 423
increases expression
ISO
Cytarabine results in increased expression of ZNF423 mRNA
CTD
PMID:21198554
NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373
G
Zfp467
zinc finger protein 467
decreases expression
ISO
Cytarabine results in decreased expression of ZNF467 mRNA
CTD
PMID:21198554
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
G
Zfpm2
zinc finger protein, multitype 2
decreases expression
ISO
Cytarabine results in decreased expression of ZFPM2 mRNA
CTD
PMID:21198554
NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Netilmicin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all